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Over one million invasive coronary angiography procedures are performed 
annually in patients who experience chest pain or are known to have coronary artery 
disease. The procedure is carried out to ascertain the degree of arterial blockage (stenosis) 
that hinders blood flow to the heart. A cardiologist performing the procedure determines 
the physiological degree of a stenosis by either visual estimation, which is routine 
practice, or by invasively measuring fractional flow reserve (𝐹𝐹𝑅), which is the current 
gold standard that has been demonstrated to improve patient outcomes and temper the 
cost of healthcare. Nevertheless, 𝐹𝐹𝑅 is performed in only 10–20% of patients because it 
is invasive, expensive, and requires more radiation exposure. 
New computational methods utilizing three-dimensional renderings processed 
from coronary angiograms can provide an accurate, highly sensitive, non-invasive 
method to assess stenotic significance without using 𝐹𝐹𝑅. While beneficial, this 
technique requires intensive computer processing power and calculation runtimes on the 
order of several hours. An approach to reduce computational time involves alike 
computing of two-dimensional arterial slices cut from the three-dimensional source 
renderings.  
The main objective was to determine if two-dimensional processing can also 
provide an accurate and highly sensitive method to assess stenotic significance at a 
fraction of the computational expense. Blood flow was analyzed in five patient cases 
below and five patient cases above the commonly accepted 𝐹𝐹𝑅 threshold value for 
intervention of 0.80. Following the generation of two orthogonal slices from DICOM-
derived three-dimensional renderings, pulsing blood flow was simulated with CFD, and 
vii 
 
multiphase mean age theory was applied to calculate the mean age of red blood cells as a 
diagnostic metric. 
Two-dimensional processing typically exhibited a correlation with 𝐹𝐹𝑅 only in 
the geometries of vertically-oriented slices. This was ascribed to the possibility of 
uncaptured stenotic blood flow characteristics in the limited testing of only two angles of 
a full arterial segment. Mean ages for the three-dimensional cases were many orders of 
magnitude higher than those of the corresponding two-dimensional cases. This was 
attributed to red blood cell collisions and distal recirculatory eddies near a stenosis being 
less expressed in the simplicity of the two-dimensional slices when compared to the 
complexity of the three-dimensional source renderings.  
A mean age threshold for determining stent intervention was estimated for the 
two-dimensional cases since limited sample size disallowed rigorous statistical analysis. 
The data suggested an arbitrary value equal to ~2.5. Nine out of ten cases correlated with 
𝐹𝐹𝑅, with just one false negative diagnosis. In published virtual 𝐹𝐹𝑅 techniques, false 
diagnosis typically occurs in 10–13% of the cases. 
Computational runtime for two-dimensional cases was less than 2% of the 
runtime for corresponding three-dimensional cases. Preliminary results indicate two-
dimensional processing may efficiently detect and assess stenoses non-invasively, 
provided that it holds up to rigorous statistical analysis following testing of at least 80–






𝑎 = mean age 
𝑎𝑖, 𝑎1, 𝑎3 = components 𝑖, 1, and 3 of an imparting velocity vector 
𝑏𝑗, 𝑏2, 𝑏4 = components 𝑗, 2, and 4 of an imparting velocity vector 
𝐶 = concentration of a passive scalar 
𝐶(𝑥, 𝑡) = concentration of a passive scalar at a location 𝑥 and time 𝑡 
𝐶𝐹𝑅 = coronary flow reserve 
𝐶𝑜𝑢𝑡 = flow-weighted average concentration across the exit plane 
𝐷 = molecular diffusivity 
𝐷𝑒 = effective turbulent diffusivity 
𝐹𝐹𝑅 = fractional flow reserve 
𝐹𝐹𝑅𝐶𝑇 = fractional flow reserve derived from coronary CTA 
?⃗? = gravitational force per unit mass vector 
𝑖̂ = unit vector in the direction of 𝑖 
𝑗̂ = unit vector in the direction of 𝑗 
?̂? = normal outward vector at the surface 
𝑝 = pressure 
𝑝𝑎 = pressure of an artery proximal to a stenosis 
𝑝𝑑 = pressure of an artery distal to a stenosis 
𝑝𝑜𝑢𝑡𝑙𝑒𝑡 = outlet pressure 
𝑝𝑣 = pressure of associated vein 
𝑅 = resistance 
𝑆 = surface of a control volume 
𝑆𝑚 = source mass added to the continuous phase from the dispersed second 
phase (or any user-defined sources) 
𝑡 = time 
𝑡̅ = mean residence time 
𝑢 = general dependent variable 
𝑢𝑖 = discretized analog of 𝑢 with values of 𝑖 
𝑢𝑖−1 = previous term of the discretized analog of 𝑢 with values of 𝑖 dictated by 
a Taylor series expansion 
?⃗? = total velocity vector 
𝑣𝑖𝑛𝑙𝑒𝑡 = inlet velocity 
𝑥 = general independent variable 
𝑥𝑖 = grid points with values of 𝑖 
𝑥𝑛 = normal coordinate in the direction of flow 
𝑦 = general independent variable 
𝛼(𝑥, 𝑡) = phasic volume fraction of an individual phase at a location 𝑥 and time 𝑡 
𝜹 = unit tensor 
𝜇 = viscosity 
𝜌 = density 
𝝉 = shear stress 
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Cardiovascular diseases are a frequent aggressor of health in today’s society, and 
they remain pervasive as a result of easily disregarded risk factors such as poor diet and 
sedentary lifestyles. Coronary artery disease (CAD) is the most prominent type of 
cardiovascular disease, and it is the leading cause of mortality worldwide. CAD signifies 
the existence of inflammatory atherosclerosis affecting the inner wall of coronary arteries 
in an occlusive manner. Directly, plaques may accrete in response to fibrosis and 
calcification, leading to the thickening of the inner wall of arteries and advancing the 
constriction of arterial lumina to cause a stenosis.  
The predominance of cardiovascular diseases such as CAD has generated 
significant interest in the areas of associated risk factor analysis, prevention, and the 
development of uncomplicated diagnosis. Presently, invasive coronary angiography 
(ICA) employs catheterization to obtain a moving picture of the coronary system, but a 
limitation of this utility arises from its incapacity to enumerate the physiological extent of 
stenoses. As a result, the metric of fractional flow reserve (𝐹𝐹𝑅) was developed to assess 
the fraction of maximal blood flow that may be achieved in a stenotic artery by 
invasively measuring a ratio of pressures distal and proximal to a stenosis. A measured 
𝐹𝐹𝑅 value less than 0.80 is the threshold below which a cardiologist intervenes with stent 
placement to prevent ischemia. The invasive determination of 𝐹𝐹𝑅 has risen to represent 
the current gold standard for decision making on stent placement. 
Current research has extended the topic of 𝐹𝐹𝑅 to its use in non-invasive, 
computationally-derived techniques such as coronary computed tomography angiography 




(𝐹𝐹𝑅𝐶𝑇) has emerged to become an innovative and non-invasive technique for evaluation 
of stenoses. 𝐹𝐹𝑅𝐶𝑇 is calculated from hyperemic blood flow simulated in arterial 
renderings using computational fluid dynamics (CFD) to determine the possibility of 
CAD and the extent of stenoses. Its adoption, however, is largely dependent on the 
monumentally challenging prospect of the medical industry’s acceptance of coronary 
CTA as a successor to ICA. 
This thesis investigates a presently competing approach that utilizes CFD and 
multiphase mean age theory to unite angiography with a non-invasive stenotic evaluator. 
Multiphase mean age theory is a concept founded on principles of residence time 
distributions (RTDs) and mean age distributions developed by Danckwerts in the 1950s. 
Mean age distributions overcome the limitation of discrete sampling at the system exit 
typically associated with RTDs, thereby providing full insight into the spatial distribution 
of mixing throughout an entire system volume. Nevertheless, mean age distributions are 
largely impractical to develop experimentally due to the contingency of measuring an 
applied passive tracer throughout an entire system volume. CFD, however, is an ideal 
tool for spatially resolved mixing. Mean age theory and its extension to multiphase 
systems, in conjunction with CFD, redefines time as a passive scalar in the transient 
advection-diffusion equation, allowing conventionally time-based variables to be 
analyzed with a steady-state solution.  
The objectives of the work presented in this thesis were to simulate blood flow 
through arterial renderings, apply multiphase mean age theory using CFD, and compare a 
novel mean age metric determined from two-dimensional arterial slices with those that 




dimensional arterial renderings. The most significant outcome if similar results were 
obtained between three- and two-dimensional processing would be reduced 
computational runtime. A shortcoming of CFD processing of three-dimensional flow 
arises from considerably lengthy calculation runtimes. Even with parallel computing on 
up to 20 processors, calculations can approach a total duration on the order of several 
hours to simulate multiphase flow in a typical three-dimensional segment of an artery. 
Simulating flow in a two-dimensional slice of the same segment takes on the order of 
about 60 minutes. 
 With the motivation of the content of this thesis considered, the specific 
objectives are: 
1) generate two-dimensional arterial slices from three-dimensional source 
renderings using computer-aided design software packages; 
2) use multiphase mean age theory in conjunction with CFD modeling to simulate 
blood flow in five two-dimensional cases above and five two-dimensional 
cases below the 0.80 𝐹𝐹𝑅 threshold value; and 
3) compare the mean age metric determined from the two-dimensional arterial 











II. LITERATURE REVIEW 
A. Coronary Artery Disease (CAD) 
1. General Information: Pathophysiology and Epidemiology 
Coronary artery disease (CAD) is a cardiovascular disease typified by plaque 
buildup in the walls of the arteries that supply blood to the heart and other parts of the 
body. CAD refers to the process of atherosclerosis pathologically affecting coronary 
arteries, and the disease includes a spectrum of consequential diagnoses including angina 
pectoris, myocardial infarction, silent myocardial ischemia, and sudden cardiac death 
(Hanson et al., 2013). CAD may be more descriptively defined as an inflammatory 
disease with lipid and macrophage collection on arterial walls as a result of developing 
atherosclerosis (Sun and Xu, 2014).  
Atherosclerosis is an inflammatory disease of the inner wall of coronary arteries 
that is hastened by the commonly known risk factors of high blood pressure, high 
cholesterol, tobacco use, and diabetes. Atherosclerosis is slowly progressive, however, 
and it silently develops through fibrosis and calcification (Gerber, 2007). The gradual 
accretion of plaques leads to the thickening of the inner wall of arteries, permitting, over 
time, the considerable constriction of arterial lumina (Ambrose and Singh, 2015). 
Defined as stenosis, the narrowing of arterial passageways is the foundational point of 
concern for CAD and its resultant diagnoses. When plaques hinder a coronary lumen and 
create a stenosis, blood flow is obstructed, occasionally establishing stable angina 
pectoris, a condition characterized by discomfort and pain in the chest. In other cases, the 
initiation of platelets and blood coagulation factors may occur if the thinned endothelium 




components to blood (Gerber, 2007). As a result, coronary lumen occlusion may occur, 
instigating ischemia and imparting the substantially more critical issues of unstable 
angina pectoris, myocardial infarction, silent myocardial ischemia, or sudden cardiac 
death. 
Since CAD develops slowly, strikes unexpectedly, and proliferates through easily 
unheeded risk factors (e.g., poor diet and sedentary lifestyles), it is predictably the 
leading cause of death worldwide (Finegold et al., 2012), and it is responsible for nearly 
7.3 million annual deaths and 58 million disability-adjusted life years lost worldwide 
(Sun and Xu, 2014). In the United States, CAD is estimated to affect 16.8 million people 
alone (Cassar et al., 2009). With this, an American will have a coronary-related event 
approximately every 25 seconds, and someone will die of one every minute (Hanson et 
al., 2013). While CAD is the leading cause of morbidity and mortality in advanced 
countries, its pervasiveness is amply rising in developing countries as well (Sun and Xu, 
2014). This is attributable to the broader issue of cardiovascular disease becoming 
widespread as developing countries transition epidemiologically from pestilence and 
famine to pandemics and progressive diseases (Cassar et al., 2009). In 2002, out of a 
worldwide total of 57 million deaths, around 17 million were due to cardiovascular 
disease, and CAD was responsible for nearly half of these cardiovascular deaths (Cassar 
et al., 2009). While high income countries have recently seen declines in deaths from 
CAD, continued high CAD mortality is persistent elsewhere (Finegold et al., 2012), with 
the mortality rate from cardiovascular disease predicted to reach 23.4 million in 2030 




2. Current State of Diagnosis 
The predominance of CAD has sparked widespread interest in risk factor analysis, 
prevention, and the development of uncomplicated diagnosis. While risk factors may be 
moderated by proper diet and lifestyle, testing, when needed, is sought to become 
uncomplicated and non-invasive in pursuance of enabling routine checkup and fulfilling 
time-sensitive constraints incumbent upon the disease. The tests currently available for 
CAD differ in modality and utility, and they serve to stand in comparison to the gold 
standard of invasive coronary angiography. The following list from Hanson et al. (2013) 
summarizes the current state of available tests for CAD diagnosis: 
a. Electrocardiography (ECG).  ECG is the most common test for CAD, and it 
serves to map the heart rate rhythm over a duration of time. ECG may show 
changes in electrical activity that designate ischemia or indicate previous 
complications of mild myocardial infarction. Despite this, ECG is inadequate 
for full diagnosis since some patients with CAD may produce ordinary results 
if the heart is not under any stress. 
b. Stress Test.  Stress tests involve heart evaluation during concentrated exercise 
usually on a treadmill. Since some signs of CAD may only surface if the heart 
is under exertion, ECG and blood pressure monitoring are utilized in parallel 
while a patient exercises. A patient may experience angina pectoris, and 
possible changes in electrical activity or blood pressure could designate 
ischemia. During the test, patients may also face exertional hypotension or 
hypertension. Exertional hypotension occurs when the blood pressure decreases 
to values lower than the resting systolic pressure, and it regularly signifies 




also arise, but it is usually not as troublesome as exertional hypotension and is 
simply evidence of long-term high blood pressure. 
c. Myocardial Perfusion Imaging.  Myocardial perfusion imaging utilizes 
radioactive tracers such as thallium and sestamibi to show how well blood 
perfuses several areas of the heart. These tests are typically performed with a 
stress test. The radioactive substance is injected intravenously, and a special 
camera takes images around the heart. Typical myocardium receives more 
thallium/sestamibi than myocardium being supplied by an occlusive coronary 
artery, so this test can provide partial evidence to the extent of possible CAD. 
d. Coronary Artery Calcium Computed Tomography (CT). Coronary artery 
calcium CT exploits the presence of calcium-rich components in the plaques 
created by atherosclerosis. A cardiac CT scan may be performed and placed in 
context of measured levels of calcium deposits. The supposition is that there is 
a higher chance of CAD if there is a considerable sum of measured calcium. 
The Agatston score quantifies the extent of coronary artery calcification, and it 
is ultimately used to strengthen claims of CAD diagnosis. 
e. Coronary Computed Tomography Angiography (CTA).  Coronary CTA scans 
the coronary arteries following the intravenous injection of a radioactive 
substance. An X-ray source is used to irradiate the area of pertinence to permit 
scans and images of the coronary arteries. Using computer software, algorithms 
may construct three-dimensional arterial renderings by linking images together. 
As a result, the capacity of coronary occlusion may be seen visually, enabling 




f. Invasive Coronary Angiography (ICA).  Invasive coronary angiography is the 
gold standard for CAD diagnosis due to its effectiveness. For this test, a 
catheter is threaded to the heart by initial insertion into vessels through the 
groin, arm, or neck. The heart receives an injection of a radioactive substance 
while angiographs are continually acquired. As a result, a moving picture of the 
coronary system is obtained, providing specific information about the valves 
and arterial function. Important details such as wall motion abnormalities and 
left ventricle ejection fraction may be easily evaluated from the angiograms to 
provide supportive consensus of CAD diagnosis. 
The current state of available tests for CAD diagnosis may be tabulated with additional 
metrics. Hanson et al. (2013) provide the comparison of test sensitivity, specificity, 
advantages, and disadvantages shown in TABLE 2.1: 
TABLE 2.1 
A COMPARISON OF TESTS USED FOR CAD DIAGNOSIS 
Test sensitivity and specificity refer, respectively, to the ability of a test to correctly 
identify those with the disease and the ability of the test to correctly identify those 
Test Sensitivity [%] Specificity [%] Advantages Disadvantages 
ECG 68 97 Inexpensive – 






Less useful for 
those with atypical 
CAD presentation 
Myocardial 
Perfusion Imaging 90 70 High sensitivity Expensive 
Coronary Artery 






Coronary CTA 94 82 Non-invasive 
New modality, 
expensive, 
radiation exposure  







without the disease. Using these metrics, the two angiographic techniques shown in 
TABLE 2.1 represent the best methods of examination yet simply differ in procedural 
ideation and execution. 
B. Fractional Flow Reserve (𝐹𝐹𝑅) in Angiography 
1. Definition 
While coronary angiographic techniques represent the preferred forms of 
diagnostics, a shortcoming of their value stems from their inability to characterize the 
physiological magnitude of stenoses. For hearts with normal myocardium and arteries, 
blood flow may increase three to five times in response to hyperemia induced by 
temporary occlusion (Lederman et al., 1997). For hearts with normal myocardium and a 
stenosis, the hyperemic myocardial flow gradually dampens with increasing percentages 
of stenosis, beginning at about 50% (Lederman et al., 1997). At that percentage, a 
stenosis is considered to impede full flow capability, thereby substantiating physiological 
impact. Importantly, angiographic techniques are unreliable in predicting functional flow 
consequences of a stenosis, meaning other approaches must be applied to further develop 
the physiological merit of angiographic diagnoses of CAD. 
Various methods have been used in an attempt to physiologically assess coronary 
stenoses, but the concept of fractional flow reserve (𝐹𝐹𝑅) has gained the most attention 
for clinical utility due to its emergence as a quick and accurate physiological appraisal 
technique (Lederman et al., 1997). 𝐹𝐹𝑅 is defined as the ratio of flow across a stenosis to 
putative flow in the absence of stenosis (Nørgaard et al., 2015). As a result, 𝐹𝐹𝑅 




Pijls et al. (1996) utilized the research on coronary flow reserve (𝐶𝐹𝑅) from 
Gould et al. (1974) to develop a model using translational pressure gradients to 
mathematically describe 𝐹𝐹𝑅. While 𝐶𝐹𝑅 is similar in its definition to 𝐹𝐹𝑅, its gauging 
relies on direct flow measurement. Pijls et al. (1996) overcame direct flow measurement 
reliance by modifying Poiseuille’s law, permitting the establishment of the concept of 
𝐹𝐹𝑅. Under Poiseuille’s law, the volumetric flow rate of a fluid is proportional to the 
pressure drop across the associated zone of interest and inversely proportional to flow 
resistance in that same zone. As such, the pressure drop across the resistance governs the 
volumetric flow rate through a resistant artery (Lederman et al., 1997). Supposing the 
myocardium is supplied by an artery with a stenosis, the pressure drop is obtained by 
subtracting the venous pressure from the pressure distal to the stenosis (i.e., 𝑝𝑑 − 𝑝𝑣) 
(Lederman et al., 1997). With this, supposing the same artery were not stenotic, the 
pressure drop calculation shifts to a difference in arterial and venous pressures (i.e., 𝑝𝑎 −
𝑝𝑣) (Lederman et al., 1997). Volumetric flow rates are obtained by dividing each pressure 
drop by resistance 𝑅, and a ratio of these volumetric flow rates gives: 




If, as in many circumstances, venous pressure is not elevated, Lederman et al. (1997) 
suggest 𝑝𝑣 may be excluded to give a simpler ratio: 
 𝐹𝐹𝑅 = 𝑝𝑑𝑝𝑎 (2.2) 
For normal arteries, 𝐹𝐹𝑅 is unity since 𝑝𝑑 equals 𝑝𝑎. For stenotic arteries, however, the 




2. Use in ICA and the Extension to Coronary CTA 
The use of 𝐹𝐹𝑅 in ICA procedures represents the current gold standard for 
determining whether an arterial stenosis causes ischemia (Min et al., 2015). 𝐹𝐹𝑅 
calculation begins with the induction of hyperemia with intravenous adenosine to collect 
physiological data on the flow resistance a stenosis is causing (Lederman et al., 1997). 
Using a catheter, a sensor collects the required pressures at the necessary locations across 
the suspected stenosis, calculating a value of 𝐹𝐹𝑅. An 𝐹𝐹𝑅 less than or equal to 0.80 is 
usually recognized as the limit below which a stenosis is considered to cause ischemia 
(Min et al., 2015). Knowing this threshold value, clinical strategies regarding subsequent 
procedural actions may be targeted appropriately. Specifically, coronary intervention may 
be safely deferred for vessels with an 𝐹𝐹𝑅 greater than 0.80, while coronary 
revascularization is recommended for vessels with a measured 𝐹𝐹𝑅 less than or equal to 
0.80 (Min et al., 2015). In establishing a decisive threshold value of 𝐹𝐹𝑅, improved 
clinical outcomes and reduced costs have been seen when compared to an ICA only, non-
𝐹𝐹𝑅 examination (Min et al., 2015). Ultimately, the addition of the physiological 
component of 𝐹𝐹𝑅 to ICA’s anatomically-based evaluations of stenosis severity facilitate 
proper coronary actions that are enduring and cost-effective (Min et al., 2012). As of yet, 
however, this methodology unifying physiological and anatomical components has not 
been available through non-invasive techniques. 
In an attempt to establish a non-invasive test that quantifies both coronary stenosis 
severity and the associated ischemia, research has increased in the topic of 𝐹𝐹𝑅 to extend 
its use in non-invasive coronary CTA. As a result, fractional flow reserve derived from 




for precise analysis of coronary ischemia caused by a stenosis. 𝐹𝐹𝑅𝐶𝑇 utilizes 
computational fluid dynamics (CFD) to assess the physiological extent of CAD. 
Importantly, CFD may be used to calculate a value of 𝐹𝐹𝑅𝐶𝑇 from previously acquired 
coronary CTA images without the need for further tomographic steps (Min et al., 2015). 
Computing 𝐹𝐹𝑅𝐶𝑇 from coronary CTA images necessitates the generation of a 
physiological model of coronary blood flow, and Nørgaard et al. (2015) describe the 
principles on which the model is established. Specifically, the first principle maintains 
that the sum of resting coronary blood flow may be computed relative to the mass of 
myocardium assessed by CT. The second principle asserts that the resting vascular 
resistance is inversely proportional to the size of the coronary arteries supplying the 
myocardium. Finally, the third principle states that the vasodilatory response to adenosine 
introduction is predictable, allowing computational modeling of hyperemia. With these 
principles established, Min et al. (2015) outline the five required steps for 𝐹𝐹𝑅𝐶𝑇 
calculation:  
1) create patient-specific anatomical models from coronary CTA; 
2) quantify the coronary artery flow in the hypothetical case in which the 
supplying vessels are normal; 
3) determine the baseline resistance for the arteries supplying the myocardium; 
4) quantify the changes in coronary resistance as a result of hyperemia; and 
5) apply CFD methods for calculation of coronary flow, pressure, and velocity at 
hyperemia. 
The grouping of the principles into three-dimensional computational models and the 




system under normal and hyperemic conditions. In doing so, 𝐹𝐹𝑅𝐶𝑇 is thusly determined 
in an analogous manner to its invasive form in ICA. 
The utilization of CFD to evaluate coronary CTA images enables the computation 
of arterial blood flow and the calculation of stenosis-specific 𝐹𝐹𝑅𝐶𝑇 without the need for 
an invasive procedure. This is to say the computation of 𝐹𝐹𝑅𝐶𝑇 enables the identification 
of patients with physiologically significant stenoses prior to invasive cardiac 
catheterization. Moreover, the utility of 𝐹𝐹𝑅𝐶𝑇 is underscored by its investigative 
potential in modeling innocuous revascularization procedures. Kim et al. (2014) show 
that the same CFD technology could be used to modify stenoses of existing flow models 
to visualize virtual stenting of a pertinent coronary area. In doing so, coronary blood flow 
and 𝐹𝐹𝑅𝐶𝑇 could be recalculated from the new model and be used to validate the 
circulatory effect of the stent on a stenosis-specific basis. Ultimately, the prediction of 
revascularization benefit via virtual approaches extends the continual non-invasive value 
of coronary CTA and its associated 𝐹𝐹𝑅𝐶𝑇. 
3. Clinical Comparison of 𝐹𝐹𝑅 and 𝐹𝐹𝑅𝐶𝑇 
While 𝐹𝐹𝑅𝐶𝑇 calculation is proven beneficial with regards to characterizing 
arterial blood flow and identifying physiologically significant coronary stenoses, its 
comparison to 𝐹𝐹𝑅 from a clinical perspective is principal in efficacy and applicability 
determination. Since its incipience of viability within the past decade, 𝐹𝐹𝑅𝐶𝑇 has gained 
clinical evidence that may be compared to the diagnostic performance of an invasive 
𝐹𝐹𝑅 reference standard (Min et al., 2015). Using a blinded comparison of 𝐹𝐹𝑅𝐶𝑇 to 
𝐹𝐹𝑅, trials involving over 600 patients and 1000 vessels assessing the diagnostic 




instances have been executed (Nørgaard et al., 2015). Using prospective designs with 
demarcations of obstructive CAD at stenoses greater than 50% and ischemia at 𝐹𝐹𝑅 or 
𝐹𝐹𝑅𝐶𝑇 values less than or equal to 0.80, Nørgaard et al. (2015) provide the comparison of 
design, population, test accuracy, sensitivity, and specificity of the studies shown in 
TABLE 2.2: 
TABLE 2.2 
STUDIES COMPARING 𝐹𝐹𝑅𝐶𝑇 DIAGNOSTIC PERFORMANCE USING 𝐹𝐹𝑅 AS 
THE REFERENCE STANDARD 












x Patients with suspected or 
known CAD who underwent 
coronary CTA, ICA, and 
𝐹𝐹𝑅. All patients had at least 
one stenosis ≥ 50% in a 
major vessel at coronary 
CTA. 
x 103 patients (159 vessels) 
x Mean age: 63 years 
x 26% female, 74% male 
x Proportion of vessels with 
𝐹𝐹𝑅 ≤ 0.80: 56% 
84 88 82 
De-FACTO 
Statistically 




x Patients with suspected or 
known CAD who underwent 
clinically indicated non-
emergent ICA after coronary 
CTA (< 60 days), and with at 
least one ICA stenosis 30–
90% 
x 252 patients (408 vessels) 
x Mean age: 63 years 
x 29% female, 71% male 
x Proportion of patients with 
𝐹𝐹𝑅 ≤ 0.80: 53 % 
73 90 54 
NXT 
Statistically 




x Patients suspected of CAD 
who underwent coronary 
CTA and ICA within < 60 
days 
x 254 patients (484 vessels) 
x Mean age: 64 years 
x 36% female, 64% male 
x Proportion of patients with 
𝐹𝐹𝑅 ≤ 0.80: 32 % 




The values listed in TABLE 2.2 represent per-vessel and per-patient diagnostic metrics 
for 𝐹𝐹𝑅𝐶𝑇 all greater than or equal to respective percentages for coronary CTA alone. 
For example, Nørgaard et al. (2015) report that the DISCOVER-FLOW study was 
concluded by obtaining per-vessel diagnostic accuracy of 84% for 𝐹𝐹𝑅𝐶𝑇 compared to 
59% for coronary CTA alone, and this arose by specificity increasing from 40% for 
coronary CTA alone to 82% for 𝐹𝐹𝑅𝐶𝑇. This shows the aptitude of 𝐹𝐹𝑅𝐶𝑇 in diagnosing 
CAD when compared to using coronary CTA on its own. With this, Nørgaard et al. 
(2015) also report an increased capacity to discern ischemia on a per-vessel and per-
patient basis. This is due to consistent increases in respective area under receiver 
operating characteristics curves—a measure of how well a parameter can distinguish 
between two diagnostic groups (i.e., having and not having ischemia)—for each 
percentage entry in TABLE 2.2. As a result, 𝐹𝐹𝑅𝐶𝑇 derived from coronary CTA images 
using 𝐹𝐹𝑅 as the reference standard provides high diagnostic performance in patients 
with supposed CAD, thereby encouraging its use as an efficacious tool capable of 
delivering increased analytical sensitivity for anatomical evaluation of the disease and 
high specificity for physiological detection of accompanying ischemia. Ultimately, 
however, the widespread adoption of 𝐹𝐹𝑅𝐶𝑇 is dependent on the exigent prospect of the 
medical industry accepting coronary CTA as a successor to ICA. 
C. Computational Fluid Dynamics (CFD) 
1. General Information: Conservation and Discretization 
Computational fluid dynamics (CFD) is a segment of fluid mechanics that solves 
fluid flow problems by employing numerical methods and data processing techniques. 




energy are of distinct importance. CFD programs offer the ability to solve these otherwise 
impractical conservation equations effectively and simultaneously. By solving the 
conservation equations using a discretized version of a geometric domain, ANSYS 
programs such as Fluent and CFX can simulate fluid flow and calculate relevant fluid 
metrics of user-based preference. In general, these programs have become ubiquitous in 
modeling, permitting the simulation of flow, heat transfer, and reactions for industrial 
applications—ranging from air flow over an aircraft wing to combustion in a furnace, 
from bubble columns to oil platforms, and from blood flow to wastewater treatment 
plants (Software: CFD Simulation, 2017). 
The combination of governing conservation equations used to solve CFD cases 
depend on the individual system to be modeled. While the equation for energy 
conservation is only necessary for problems involving energy transfer, all systems must 
solve the conservation equations of mass and momentum. For the conservation equation 
of mass, continuity is described by: 
 𝜕𝜌𝜕𝑡 + (∇ ⋅ 𝜌?⃗?) = 𝑆𝑚 (2.3) 
The conservation equation of momentum is: 
 𝜕𝜕𝑡 (𝜌?⃗?) + ∇ ⋅ 𝜌?⃗??⃗? = −∇𝑝 − [∇ ⋅ 𝝉] + 𝜌?⃗? (2.4) 
The viscous momentum flux tensor 𝝉 represents shear stress and is given by: 
 𝝉 = −𝜇[∇?⃗? + (∇?⃗?)𝑇] + 23 𝜇(∇ ⋅ ?⃗?)𝜹 (2.5) 
Assuming constant fluid density and viscosity, substitution of 𝝉 in the conservation 




 𝜌 (𝜕?⃗⃗?𝜕𝑡 + ?⃗? ⋅ ∇?⃗?) = −∇𝑝 + 𝜇∇
2?⃗? + 𝜌?⃗? (2.6) 
The conservation of mass and Navier-Stokes equations are solved in CFD 
software by approximating the continuous variables in the partial differentials by discrete 
analogs and utilizing a discretized domain of a geometric mesh or grid. While continuous 
domains have flow variables defined at every point on the domain, discrete ones have 
flow variables defined only at the grid nodes. If each node interacts with adjacent nodes 
predictably, an accurate solution may be obtained. If the grid resolution (i.e., mesh count) 
is sufficient, discretized results approach analytical ones. 
The simplest technique of discretization comes from the finite-difference method. 
For illustration of this method, Bhaskaran and Collins (2002) utilize a linear one-
dimensional differential equation: 
 𝑑𝑢𝑑𝑥 + 𝑢 = 0; 0 ≤ 𝑥 ≤ 1; 𝑢(0) = 1 (2.7) 
The domain may be discretized into equally-spaced points on a grid, with general grid 
points labeled 𝑥𝑖. Since the governing equation is valid for all 𝑥𝑖, the discretized form of 
Equation (2.7) is: 
 (𝑑𝑢𝑑𝑥)𝑖 + 𝑢𝑖 = 0 (2.8) 
To get an equation for the differential term in terms of 𝑢 at the grid points, a Taylor series 
expansion may be used to give: 
 (𝑑𝑢𝑑𝑥)𝑖 =
𝑢𝑖−𝑢𝑖−1
∆𝑥 + 𝑂(∆𝑥) (2.9) 




 𝑢𝑖−𝑢𝑖−1∆𝑥 + 𝑢𝑖 = 0 (2.10) 
While the finite-difference method is simple, it illustrates the foundational discretization 
process. An extension to this technique that Fluent coding uses is the finite-volume 
method. In this method, integral forms of the conservation equations are applied to a cell 
of control volume to obtain discrete equations for each cell. The adjacency of control 
volumes creates a network of cells (i.e., a mesh), and the cells may be represented by a 
wide range of geometries, including those of quadrilaterals, triangles, hexahedra, 
tetrahedra, or prisms. An example of this method is illustrated by the integral form of the 
conservation equation of mass: 
 ∫ (?⃗? ⋅ ?̂?)𝑑𝑆 = 0𝑆  (2.11) 
Using an example square cell of length ∆𝑥, height ∆𝑦, and an imparting velocity vector 
of 𝑎𝑖𝑖̂ + 𝑏𝑖𝑗,̂ the discretized form of the integral equation is: 
 −𝑎1∆𝑦 − 𝑏2∆𝑥 + 𝑎3∆𝑦 + 𝑏4∆𝑥 = 0 (2.12) 
Markedly, this equation sums the net mass flow into the control volume of the example 
square cell and sets it equal to zero. By similar treatment, discrete equations for 
remaining conservation equations for the cell may be achieved. Moreover, the finite-
volume method is readily extendable to any other general cell shapes in two or three 
dimensions. 
After discretization, equations are solved simultaneously and iteratively. Fluent 
permits choices between pressure-based and density-based solvers for iteration. 
Historically speaking, the pressure-based approach was developed for low-speed 




compressible flows (Overview of Flow Solvers, 2009). Recently, however, both methods 
have been extended to solve and operate for a wide range of flow conditions beyond their 
traditional intent. In both methods, the velocity field is obtained from the conservation of 
momentum equation. For the pressure-based solver, the pressure field is extracted by 
solving a pressure equation obtained by manipulating conservation of mass and 
momentum equations. In the density-based approach, the conservation of mass equation 
is used to obtain the density field while the pressure field is determined from the equation 
of state. Several steps in the chosen iteration scheme must occur to advance the system to 
solution convergence. The two approaches of iteration schemes and the steps used to 
solve fluid flow problems are shown in FIGURE 2.1: 
 
FIGURE 2.1 - Iteration Schemes for the (a) Pressure-based and (b) Density-based Solvers 





Importantly, regardless of the solver used, convergence is checked by evaluating how 
much fluid properties have changed from the previous iteration to the current one. If the 
change (i.e., residual) is sufficiently small, the solution is converged. If not, the fluid 
properties are used as initial values for the next iteration, and the scheme repeats. 
2. Utilization in Multiphase Systems 
 Recent advances in CFD have provided the basis for mathematically modeling the 
dynamics of multiphase systems. These systems are characterized by coexisting flow of 
materials with different phases (e.g., a liquid-gas system) or materials with differing 
chemical properties in the same phase (e.g., a water-oil system). The Euler-Lagrange and 
Euler-Euler methods are the two current approaches used for modeling these multiphase 
systems. The Euler-Lagrange approach treats the fluid phase as a continuum by solving 
the time-averaged Navier-Stokes equations and solves the dispersed phase by tracking 
many particles, bubbles, or droplets through the calculated flow field (Overview, 2006). 
While the dispersed phase can exchange momentum, mass, and energy with the fluid 
phase, the Euler-Lagrange approach relies on the fundamental assumption that the 
dispersed phase occupies a low volume fraction. The particle, bubble, or droplet 
trajectories are computed individually at specified intervals during the fluid phase 
calculation, meaning intensive computational processing requirements are needed. 
 The Euler-Euler approach is dissimilar by its treatment of both phases as 
interpenetrating continua (Approaches to Multiphase Modeling, 2006). Since both phases 
are considered continuous, the concept of phasic volume fraction is used. These volume 
fractions are assumed to be continuous functions of space and time and their sum equal to 




structured equations for all phases. In Fluent, three different Euler-Euler multiphase 
models are available: volume of fluid, mixture, and Eulerian.  
The volume of fluid method is a surface-tracking technique applied to a fixed 
Eulerian mesh (Approaches to Multiphase Modeling, 2006). It is used for two or more 
immiscible fluids, with the interface between the fluids being of most interest. In this 
model, the fluids share a single set of momentum equations, and the volume fraction of 
each of the fluids in each discretized cell is tracked across the domain. Applications of 
the volume of fluid method include the modeling of spray dryers and coal and liquid fuel 
combustion. Alternatively, the mixture model solves for the mixture momentum equation 
and assigns relative velocities to describe the dispersed phases, making it appropriate for 
modeling systems of sedimentation or cyclone operators that are rich with particles. 
Finally, the Eulerian model is the most complex of the multiphase models in Fluent, and 
it solves a large set of continuity and momentum equations for each phase and couples 
the pressure and interphase exchange coefficients as a way to link solutions for each 
phase (Approaches to Multiphase Modeling, 2006). Momentum exchange between the 
phases is dependent upon the type of mixture being modeled (e.g., granular or non-
granular). Fluent's user-defined functions permit customization of the calculation of 
momentum exchange. Applications of the Eulerian method include bubble columns and 
arterial blood flow. 
D. Age Topics 
1. Residence Time Distributions (RTDs) and Mean Age Theory 
Extensive analysis of residence time distribution (RTD) and age concepts began 




(i.e., plug flow) or perfect (i.e., CSTR) were only considered and characterized, leaving a 
void in portraying real processes between these extrema. In 1953, Danckwerts modeled 
non-ideal mixing by measuring the residence time of fluid elements spent inside a 
system. Defining RTD, it is specifically a probability distribution function that expresses 
the amount of time a fluid element could spend inside a system, providing partial insight 
into non-ideal system mixing and dispersion properties. Danckwerts studied the 
probability distribution functions in a variety of vessel types and piping, establishing 
RTDs to be an operative quantifier of non-ideal mixing in real systems. While useful, a 
drawback to RTDs is that the produced function is typically limited to discrete sampling 
at the system exit, thus incognizant of characterizing internal happenings (Russ and 
Berson, 2016). In effect, an RTD provides no information regarding the spatial 
distribution of mixing along the length of a system. While the shape of the produced RTD 
function may imply the presence of dead zones in the mixing system, the location of such 
vessel areas cannot be determined from an RTD (Liu and Tilton, 2010). This prompts the 
desire to understand the spatial distribution of mixing beyond the area of exit and more 
internally.  
In hopes of extending the topic, Danckwerts reclassified the term “residence time” 
for molecules exiting the system as a way to describe the elapsed time since they entered 
and developed the concept of “age” to describe the elapsed time since entrance of 
molecules still in the system (Liu and Tilton, 2010). Consequently, when a molecule 
reaches the exit, its age equals the residence time. As suggested, complete spatial 
distributions of age are most valuable, but they are generally unfeasible to develop 




necessitate tracking the movement of a passive tracer (Russ and Berson, 2016). As a 
solution, in recent years, the application of mean age theory has provided an innovative 
approach in research associated with spatially resolved mixing. Mean age theory permits 
redefining time as a passive scalar in the transient advection-diffusion equation, 
facilitating analysis of traditionally time-based variables (e.g., mean residence time) 
while using a steady-state solution (Russ and Berson, 2016). Passive scalars may be 
thought of as virtual tracers that do not impact flow but are transported by the system as a 
way to track flow. While mean age theory was originally proposed by Danckwerts in 
1958, technological restraints withheld the topic as strictly theoretical. With the rise of 
computational fluid dynamics (CFD), however, spatially resolved solutions for mean age 
theory purposes are now possible. While conventional solutions to the advection-
diffusion equation require a time-demanding transient solution for modeling the time-
dependent tracer behavior, CFD provides robust computing of the transient solution and 
the ability to report spatial and temporal resolution within the flow field (Russ and 
Berson, 2016). 
2. Deriving Mean Age Conservation and the Extension to Multiphase Systems 
Mean age theory as an approach to modeling the time-dependent behavior of a 
passive scalar in steady-state CFD simulations has been used to determine the mean age 
conservation equation plentifully in literature for a single-phase system (Liu and Tilton, 
2010; Sandberg, 1981; Spalding, 1958). Russ and Berson (2016) extend the theory for 
multiphase systems by defining the passive scalar concentration independently for 
individual phases, permitting mean age to be solved at steady-state for each phase 




by defining a spatially resolved concentration 𝐶(𝑥, 𝑡) for the passive scalar at a location 𝑥 
and time 𝑡. This concentration function is limited in utility for application, so Russ and 
Berson (2016) extend the definition by assuming: 
 𝐶(𝑥, 𝑡) = 𝜌𝜑(𝑥, 𝑡) (2.13) 
Here, 𝜌 is the density of the single phase and 𝜑(𝑥, 𝑡) is the passive scalar value at a 
location 𝑥 and time 𝑡. It follows that the concentration of a passive scalar value for an 
individual phase in a multiphase system is: 
 𝐶(𝑥, 𝑡) = 𝜌𝜑(𝑥, 𝑡)𝛼(𝑥, 𝑡) (2.14) 
Now, 𝜌 is the density of an individual phase and 𝛼(𝑥, 𝑡) is the phasic volume fraction of 
an individual phase at a location 𝑥 and time 𝑡. Using these definitions of passive scalar 
concentration, the derivation for the mean age conservation equation follows directly 
from Liu and Tilton (2010). 
 Mean residence time for either definition of passive scalar concentration may be 
defined as: 





This may then be extended for the spatial distribution of internal happenings by defining 
mean age as: 










 𝜕𝐶𝜕𝑡 + ∇ ⋅ (?⃗?𝐶) = ∇ ⋅ (𝐷∇𝐶) (2.17) 
In this equation, 𝐷 is the molecular diffusivity. Equation (2.17) and the remaining 
derivation steps apply to laminar flow systems. In the case of turbulent flow systems, 
Equation (2.17) becomes the Reynolds averaged equation and 𝐷 is replaced by the 
effective turbulent diffusivity 𝐷𝑒, provided that the time scale of turbulence is much 
smaller than the scale of mean residence time. If that criterion is met, the remaining 
derivation steps for laminar flow systems may be altered for turbulent flow systems by 
replacing 𝐷 with 𝐷𝑒. Multiplication of Equation (2.17) by 𝑡 and integration gives: 






0  (2.18) 
Here, 𝑡 is independent of position and has been brought inside the spatial derivatives. The 
first term on the left-hand side of Equation (2.18) may be integrated by parts to give: 
 ∫ 𝑡 𝜕𝐶𝜕𝑡 𝑑𝑡
∞
0 = 𝑡𝐶|0∞ − ∫ 𝐶𝑑𝑡
∞
0  (2.19) 
The first term on the right-hand side of Equation (2.19) will be zero if 𝑡𝐶 is zero in the 
limit 𝑡 → ∞. That is, 𝐶 must approach zero faster than 𝑡 approaches infinity, indicating 
that the mean age 𝑎 can exist only if 𝑡𝐶 → 0 as 𝑡 → ∞. As such, the first term on the 
right-hand side of Equation (2.19) must equal zero so that: 
 ∫ 𝑡 𝜕𝐶𝜕𝑡 𝑑𝑡
∞
0 = − ∫ 𝐶𝑑𝑡
∞
0  (2.20) 
Substitution of Equation (2.20) into Equation (2.18) and division by ∫ 𝐶𝑑𝑡∞0  gives: 












Lastly, substituting the definition of 𝑎 (Equation (2.16)), the general conservation 
equation for mean age is: 
 ∇ ⋅ (?⃗?𝑎) = ∇ ⋅ (𝐷∇𝑎) + 1 (2.22) 
Equation (2.22) may be simplified for incompressible flow in single-phase systems to 
give: 
 ?⃗? ⋅ ∇𝑎 = ∇ ⋅ (𝐷∇𝑎) + 1 (2.23) 
Equation (2.22) mirrors the same form as the conservation equations of mass and 
momentum, enabling solution by the same CFD solver. It is noted that both definitions of 
𝐶(𝑥, 𝑡) produce the same conservation equation, so mean age theory is now presently 
extended from single-phase to multiphase systems. Liu and Tilton (2010) derive 
boundary conditions for the conservation equation for mean age and are based on tracer 
concentration. Utilizing Equation (2.16) and the normal coordinate in the flow direction 
𝑥𝑛, Liu and Tilton (2010) show that suitable boundary conditions for Equations (2.22) 
and (2.23) are: 
 𝑎 = 0, at inlet (2.24) 
 ?̂? ⋅ ∇𝑎 = 𝜕𝑎𝜕𝑥𝑛 = 0, on solid walls (2.25) 
 ?̂? ⋅ ∇𝑎 = 𝜕𝑎𝜕𝑥𝑛 = 0, at outlet (2.26) 
Russ and Berson (2016) show that multiphase mean age theory is well validated 
by comparing experimental RTDs obtained from spatial mean age distributions to ones 




values and variances from multiphase mean age theory were within 1–3% and 3–11%, 
respectively, of experimental values. With this, mean RTD values and variances derived 
from multiphase mean age theory neared experimental values more closely than 
respective values derived from conventional transient solutions, indicating the innate 
steady-state solution associated with the theory increased the accuracy (Russ and Berson, 
2016). Multiphase mean age theory is applicable to systems of any phase type, and since 
steady-state solutions are utilized, the theory is valuable for systems with lengthy 




III. EXPERIMENTAL METHODS 
A. Preliminaries 
1. Purpose 
The purpose of this investigation was to utilize CFD and multiphase mean age 
theory as a way to compare a novel mean age metric determined from two-dimensional 
arterial slices with those that are used to detect and assess a stenotic artery determined 
from corresponding three-dimensional arterial renderings. Using supercomputing, 
calculations can approach a total duration on the order of days to simulate multiphase 
flow in a typical three-dimensional segment of an artery. Comparatively, simulating flow 
in a two-dimensional slice of the same segment takes on the order of about 60 minutes. If 
two-dimensional slicing can produce a similar mean age metric to its three-dimensional 
source, the more easily-processed, two-dimensional slices may be preferentially chosen 
to aid in long-term three-dimensional correlative approaches to 𝐹𝐹𝑅. 
2. Plan 
Two-dimensional arterial slices were generated from the three-dimensional source 
arteries using the computer-aided design software packages of ANSYS SpaceClaim and 
Dassault Systèmes SolidWorks. To better capture a wider range of the three-dimensional 
geometries, two orthogonal slices were created within each artery, giving two sets of ten 
(or 20 slices in total) to process. SpaceClaim was used to create two separate STEP files 
representing the three-dimensional arterial outlines, while SolidWorks was used to 
convert the outlines to two-dimensional surface entities via filling, flattening, and 
aligning. ANSYS Meshing was then used to create a discretized domain of a geometric 




to simulate pulsing blood flow and to calculate the mean ages of the plasma and red 
blood cell phases using user-defined scalars. From this, the mean ages of the two-
dimensional slices were compared to nominal mean residence times to characterize the 
age impact of an occurring stenosis. Finally, the mean ages of the two-dimensional slices 
were then compared to respective three-dimensional mean age values of the source 
renderings for final assessment. 
B. Materials 
A Lenovo ThinkPad with an Intel Core i5-3320M CPU @ 2.60 GHz was used to 
run the ANSYS 17.1 software packages of Workbench, SpaceClaim, Meshing, and 
Fluent on Windows 7. With this, a MacBook Pro with an Intel Core i5-6267U CPU @ 
2.90 GHz was used in conjunction with Parallels Desktop for Mac to run Dassault 
Systèmes SolidWorks on Windows 10. 
DICOM-derived, three-dimensional STL files of arteries rendered by coronary 
angiograms were provided for slicing treatment. User-defined function (UDF) files were 
used to generate pulsing at the boundaries. Each UDF differs by multiplicative constants 
on the piecewise functions of Equations 3.1 and 3.2: 
 𝑣𝑖𝑛𝑙𝑒𝑡 = {
0.1,
0.26 sin(1.58𝜋(𝑡 + 0.92)),                          
0 < 𝑡 ≤ 0.42
0.42 < 𝑡 ≤ 0.9 (3.1) 
 𝑝𝑜𝑢𝑡𝑙𝑒𝑡 = {18665.13 sin(1.4𝜋(0.8𝑡 + 0.1305)) ,−13400𝑡 + 22700,     
0 < 𝑡 ≤ 0.42
0.42 < 𝑡 ≤ 0.9 (3.2) 




C. Procedures for Processing Two Orthogonal Arterial Slices 
1. Geometry Generation 
Arterial slice geometry was generated using ANSYS Workbench and the two 
computer-aided design software packages of ANSYS SpaceClaim and Dassault Systèmes 
SolidWorks. The following steps describe how to create arterial slices from three-
dimensional arteries: 
a. SpaceClaim.  SpaceClaim was used to create two separate STEP files 
representing the three-dimensional arterial outlines. 
i. New Geometry Module and SpaceClaim File.  Open Workbench and 
drag a new Geometry module from the Toolbox pane to the Project 
Schematic pane. Right-click the Geometry module and click “New 
SpaceClaim Geometry...” to open SpaceClaim. 
ii. Opening the STL File.  Click File → Open and navigate to the three-
dimensional STL file. Before opening the file, click “Options...” in the 






FIGURE 3.1 - STL File Opening Settings in SpaceClaim 
Click “OK” in the SpaceClaim Options window and click “Open” in the 
Open window to import the three-dimensional geometry. Importantly, 
the geometry will have boundaries of a single face nearly circular in 
shape, while the wall will be composed of hundreds of faces of various 
shape. 
iii. Line Creation.  Orthogonal markers are needed on both boundary faces 
to guide slice creation. To create orthogonal markers, choose Line from 
the ribbon. Under the Options - Sketch pane on the left, ensure the 





FIGURE 3.2 - Line Options in SpaceClaim 
With Line selected from the ribbon, a grid will display on the drawing 
space. Move the cursor to a boundary face so that the grid displays 
major axes on it. FIGURE 3.3 displays this: 
 
FIGURE 3.3 - Major Axes Displayed on a Boundary Face in 
SpaceClaim 
Zooming in, draw two orthogonal lines on a boundary face that extend 
beyond the length of the face. The grid should be used to snap the lines 





FIGURE 3.4 - Two Orthogonal Lines Extending Beyond a Boundary 
Face in SpaceClaim 
With the two lines now extending beyond a boundary face, the lines 
must be reduced to the constraints of the face itself. Click Select from 
the ribbon and choose one of the four line endpoints. Using a 
combination of zooming and panning, hold the Shift key and drag the 
endpoint to the extent of the associated boundary face. Repeat this 
process for the remaining three endpoints so that the lines match that of 
FIGURE 3.5: 
 
FIGURE 3.5 - Two Orthogonal Lines Reduced to the Extent of a 




Rotating the object so that the other boundary face is visible, repeat this 
process of line creation on it. It is noted that the major axes used for the 
first face will be presented by default on the second face, and this 
ensures respective “horizontal” and “vertical” lines are kept similar. In 
total, four lines should be created. Alike lines from both faces serve as 
the boundary lines for the arterial slices. For organizational purposes, 
right-click the lines in the Structure pane and rename alike lines as 
Line1_1 and Line1_2 for Slice 1 and as Line2_1 and Line2_2 for Slice 
2. The distribution of names is shown in FIGURE 3.6, where the three-
dimensional object has been suppressed from visibility to make line 
discernment easier: 
 
FIGURE 3.6 - Line Name Distribution in SpaceClaim 
It is also noted here that the lines ending in “_1” denote what will 
eventually become inlet boundaries. The designation of inlet and outlet 
boundaries stems from choosing the face with the larger surface area to 
be the inlet. 
iv. Spline Creation.  Splines are needed on the wall of the artery to create an 




SpaceClaim defaults to two-dimensional creation, so type the D key to 
activate three-dimensional space control. Begin a spline creation by 
clicking the intersection point between a line created in iii and the 
perimeter of a boundary face. Using a combination of rotating, zooming, 
and panning, click points along the length of the wall of the artery until a 
connection is made to the alike line/boundary intersection. The initial 
creation of a spline is shown in FIGURE 3.7: 
 
FIGURE 3.7 - Initial Spline Creation in SpaceClaim 
The completed spline extending the length of the artery is shown in red 
in FIGURE 3.8: 
 




Again, connection must be made to the respective line on the other end 
of the artery. Viewing FIGURE 3.7, it is clear that the arterial wall is 
composed of numerous faces. Splines snapping to the edges of these 
faces provides a difficulty in creating connections that stay consistent 
with the curvature of the geometry. Special care in guaranteeing 
acceptable spacing between clicked points must be taken to ensure an 
adequate connection between boundary lines is made. Rotating the 
object so that the other line/boundary intersections are visible, repeat this 
process of spline creation. In total, four splines should be created that are 
nearly equally spaced and form a frame of the artery. Alike splines from 
the same axis serve as the wall for the arterial slices. For organizational 
purposes, right-click the splines in the Structure pane and rename alike 
splines as Spline1_1 and Spline1_2 for Slice 1 and as Spline2_1 and 
Spline2_2 for Slice 2. Using red and green, the distribution of names is 
shown in FIGURE 3.9, where the three-dimensional object has been 
suppressed from visibility to make spline discernment easier: 
 




It is noted that the outlines for each slice are now created. It is 
recommended to click File → Save As and save as a SpaceClaim file to 
create a file checkpoint to start from should downstream issues arise. 
v. Saving As a STEP File.  The outlines of the two slices must be saved 
individually for proper analysis hereafter. To begin the process of saving 
the first slice outline, delete all geometry in the Structure pane aside 
from the two lines and two splines outlining a slice. For example, to 
isolate the outline of Slice 1, right-click and delete the arterial body 
denoted as Solid, Line2_1, Line2_2, Spline2_1, and Spline2_2 in the 
Structure pane. In doing so, the outline for Slice 1 should be solely 
present. FIGURE 3.10 displays the Structure pane (a) before and (b) 
after deletion of Slice 2 components: 
 
FIGURE 3.10 - Structure Pane (a) Before and (b) After Deletion of Slice 





 In performing the above deletions, the only remaining components of 
geometry are those which outline Slice 1, and this is shown in FIGURE 
3.11: 
 
FIGURE 3.11 - Components of Geometry Outlining Slice 1 After 
Deletion of Slice 2 Components in SpaceClaim 
With only the outline of Slice 1 present, click File → Save As. In the 
Save As window, ensure the options highlighted in FIGURE 3.12 are 
followed: 
 





Click “Save” in the Save As window to create a three-dimensional STEP 
file for Slice 1. Finally, the saving process must be repeated for Slice 2. 
With SpaceClaim still open, undo the previous deletion of Slice 2 
geometry (returning to file checkpoint) and invert the components to be 
deleted and delete them. Accordingly, to isolate the outline of Slice 2, 
right-click and delete the arterial body denoted as Solid, Line1_1, 
Line1_2, Spline1_1, and Spline1_2 in the Structure pane. In doing so, 
the outline for Slice 2 should be solely present. Repeat the Save As steps 
represented by FIGURE 3.12 to create a STEP file for Slice 2. Two 
separate STEP files representing the three-dimensional arterial outlines 
have been created and are in position for SolidWorks treatment. 
b. SolidWorks.  SolidWorks was used to convert the three-dimensional arterial 
outlines to two-dimensional surface entities via filling, flattening, and aligning. 
i. New SolidWorks File.  Open SolidWorks. Click File → Open and 
navigate to one of the three-dimensional arterial outline STEP files 
created in SpaceClaim. Click “Open” in the Open window to import the 
three-dimensional geometry. Importantly, the geometry is a three-
dimensional outline in position for two-dimensional surface conversion 
via filling, flattening, and aligning. 
ii. Filling the Outline.  Choose Filled Surface from the ribbon. With the 
blue Patch Boundary box highlighted in blue, select the geometric 
outline. The three-dimensional outline will fill to create a surface, which 





FIGURE 3.13 - Fill Surface Pane Magnified and the Three-Dimensional 
Outline Being Filled in SolidWorks 
Click the green checkmark under the Fill Surface pane on the left to 
confirm the filling. 
iii. Flattening the Three-Dimensional Surface.  Choose Surface Flatten from 
the ribbon. With the blue Face/Surface to Flatten box highlighted blue, 
select the surface. With the pink Vertex or Point on Edge to Flatten 
From box highlighted blue, select one of two boundary lines. Finally, 
click and drag the Accuracy handle to High. The three-dimensional 
surface will flatten to create a two-dimensional surface, which is shown 





FIGURE 3.14 - Flatten Pane Magnified and the Three-Dimensional 
Surface Being Flattened in SolidWorks 
Click the green checkmark under the Flatten pane on the left to confirm 
the flattening. 
iv. Aligning the Surface.  Click Insert → Surface → Move/Copy... to 
initiate the aligning process. With the Bodies to Move box highlighted in 
blue, select the flattened surface. With Mate Settings box highlighted 
blue, select the flattened surface and the default Front Plane. Ensure 
Coincident is chosen below the Mate Settings box. The flattened surface 






FIGURE 3.15 - Move/Copy Body Pane Magnified and the Two-
Dimensional Surface Being Aligned in SolidWorks 
Click the green checkmark under the Move/Copy Body pane on the left 
to confirm the aligning. 
v. Deleting the Three-Dimensional Surface.  Two objects are visible at this 
point, but the remaining three-dimensional surface must be deleted. 
Opening the Surface Bodies folder in the hierarchy pane, right-click the 
filled surface and click Delete/Keep Body... to open the Delete/Keep 
Body... pane. Ensure the Delete/Keep Body... pane shows Delete Bodies 
under Type and the Bodies to delete box highlighted in blue shows the 





FIGURE 3.16 - Delete/Keep Body... Pane Magnified and the Three-
Dimensional Surface Being Deleted in SolidWorks 
Click the green checkmark under the Delete/Keep Body... pane on the 
left to confirm the deletion. Only a two-dimensional slice oriented on the 
XY-plane remains. 
vi. Saving As a STEP File.  The two-dimensional slice must be saved as a 
STEP file for proper analysis hereafter. Click File → Save As. In the 
Save As window, ensure the STEP AP203 file format is chosen. Click 
“Save” in the Save As window to create a two-dimensional STEP file 
for Slice 1.  
vii. Repeat for Slice 2.  Repeat the above steps in the SolidWorks subsection 
for the three-dimensional Slice 2 STEP file generated from SpaceClaim. 
As a result, two separate STEP files representing the filled, flattened, 
and aligned two-dimensional arterial slices have been created and are in 




2. Mesh Generation 
The two generated arterial slices were meshed using the software of ANSYS 
Meshing. The following steps describe how to create a suitable mesh: 
a. Preliminary Setup.  Workbench and Meshing are used to structure the 
introductory arrangement of mesh generation. 
i. New Fluid Flow (Fluent) Module and Importing the Geometry File.  In 
Workbench, drag a new Fluid Flow (Fluent) module from the Toolbox 
pane to the Project Schematic pane. This module is added next to the 
previously inserted Geometry module. FIGURE 3.17 displays the 
Project Schematic setup: 
 
FIGURE 3.17 - Project Schematic Pane with Geometry and Fluid Flow 
(Fluent) Modules in Workbench 
To import the proper geometry, right-click the Geometry cell in the 
Fluid Flow (Fluent) module and click Import Geometry → Browse... and 
browse to one of the two-dimensional arterial slice STEP files created in 
SolidWorks. Click “Open” in the Open window. A green checkmark 




ii. Initial Meshing Preferences.  Open Meshing by double-clicking the 
Mesh cell in the Fluid Flow (Fluent) Module. In Meshing, click Mesh 
from the Outline pane on the left. The Details of “Mesh” pane will 
display under the Outline pane. In the Details of “Mesh” pane, ensure 
Fluent is chosen as the Solver Preference under the Defaults group. In 
the same pane, choose “Proximity and Curvature” for Size Function and 
“Fine” for Relevance Center under the Sizing group. These preferences 
are highlighted in FIGURE 3.18: 
 
FIGURE 3.18 - Details of “Mesh” Pane Preferences in Meshing 
b. Meshing Controls.  Controls must be applied to construct a working mesh. 
i. Body Sizing.  Right-click Mesh from the Outline pane and click Insert. 





FIGURE 3.19 - Insert Controls in Meshing 
Click Sizing. The Details of “Mesh” pane will convert to the Details of 
“Sizing” - Sizing pane. Geometry under the Scope group will display No 
Selection. To select the proper geometry, click the green Body tool from 
the ribbon and select the slice in the Geometry space. The slice will turn 
green. In the Details of “Sizing” - Sizing pane, click Apply for 
Geometry under the Scope group. FIGURE 3.20 displays the resulting 
pane, which converts to “Body Sizing” after clicking Apply: 
 




Importantly, Geometry under the Scope group displays “1 Body,” 
confirming proper selection has been made. 
ii. Inflation.  Right-click Mesh from the Outline pane again and click 
Insert. As seen in FIGURE 3.19, click Inflation. Geometry under the 
Scope group and Boundary under the Definition group will display No 
Selection. To select the proper geometry, click the green Face tool from 
the ribbon and select the slice face in the Geometry space. The slice face 
will turn green. In the Details of “Inflation” - Inflation pane, click Apply 
for Geometry under the Scope group. In a similar manner, click the 
green Edge tool from the ribbon and select the two wall edges of the 
slice in the Geometry space. The two wall edges of the slice will turn 
green. In the Details of “Inflation” - Inflation pane, click Apply for 
Boundary under the Definition group. With this, change the number of 
inflation layers to “10” by toggling to the number for Maximum Layers 
under the Definition group. FIGURE 3.21 displays the resulting pane: 
 




Importantly, Geometry under the Scope group displays “1 Face,” 
Boundary under the Definition group displays “2 Edges,” and the 
Maximum Layers under the Definition group displays 10, confirming 
proper selections and settings have been made.  
iii. Named Selections.  For downstream Fluent processing, Named 
Selections must be applied to the inlet, outlet, wall, and interior of the 
slice. To define the inlet, begin by clicking the green Edge tool from the 
ribbon and selecting the larger of the two boundary edges. Right-click 
and choose Create Named Selection. Name the selection as inlet in the 
Selection Name window, ensure Apply selected geometry is ticked, and 
click “OK.” FIGURE 3.22 displays the process of creating a Named 
Selection for the inlet: 
 
FIGURE 3.22 - Creating a Named Selection for the Inlet in Meshing 
Repeat the process for the outlet, wall, and interior. The outlet is the 
other boundary edge, while the wall is defined by the same wall edges as 
in the Inflation steps. The interior is the face of the slice, and it is named 
“artery” for clarity. This, and the remaining distribution of color-coded 





FIGURE 3.23 - Named Selection Distribution in Meshing 
c. Processing and Requirements.  Proper processing to achieve set mesh 
requirements must occur to create a final mesh suitable for downstream use. 
i. Mesh Construction and Mesh Count.  Begin the meshing process by 
clicking Generate Mesh at the top of the ribbon. After processing, click 
Show Mesh at the top of the ribbon to display the mesh. Upon 
inspection, inflation layers line the wall and a mesh has been created, but 
the mesh count must be checked for acceptable resolution. To begin the 
check, click Mesh from the Outline pane on the left. The Details of 
“Mesh” pane will display under the Outline pane. In the Details of 
“Mesh” pane, review Elements under the Statistics group. This is 





FIGURE 3.24 - Checking Mesh Count in the Details of “Mesh” Pane in 
Meshing 
The number associated with Elements represents the mesh count. This 
value should be no less than 20,000. The mesh count is increased by 
decreasing the Element Size under the Definition section in the Details 
of “Body Sizing” - Sizing pane, which is seen in FIGURE 3.20. 
Typically, an Element Size of 0.10 mm will produce a mesh count near 
20,000. After changing the Element Size value in FIGURE 3.20, click 
Generate Mesh again, inspect the mesh using Show Mesh, and check the 
mesh count in the Details of “Mesh” Pane for a value of at least 20,000. 
ii. Repeat for Slice 2.  Repeat the above steps in the Mesh Generation 
subsection for the other two-dimensional arterial slice STEP file created 
in SolidWorks. As a result, two separate modules containing the meshed 




3. Fluent Case Processing 
Blood flow through the two meshed arterial slices was simulated using the 
software of ANSYS Fluent. The following steps describe how to run a suitable case: 
a. Preliminary Setup.  Workbench is used to structure the introductory 
arrangement of Fluent cases. 
i. Opening Fluent Launcher and Fluent.  In Workbench, double-click the 
Setup cell in the previously inserted Fluid Flow (Fluent) Module. Fluent 
Launcher will open. Verify that the default settings restrict 2D for 
Dimension, and ensure the setting highlighted in FIGURE 3.25 is 
followed: 
 
FIGURE 3.25 - Fluent Launcher Window in Workbench 
Click “OK” to open Fluent. 
b. Setup.  The Setup group in the Tree hierarchy arranges the most common 
system setup tasks. 
i. General.  Click General in the Tree hierarchy to display the General 





FIGURE 3.26 - General Pane in Fluent 
ii. Models.  Click Models in the Tree hierarchy to display the Models pane, 
and select Multiphase - Off. To activate this model, click “Edit...” at the 
bottom of the Models pane. The Multiphase Model window will open, 
where the settings highlighted in FIGURE 3.27 should be applied: 
 




Click “OK” to activate the model. In the Models pane, activation is 
complete if the model displays “Multiphase - Eulerian.” With this, 
ensure that the Viscous model displays the default “Viscous - Laminar.”  
iii. Materials.  Click Materials in the Tree hierarchy to display the Materials 
pane. Default fluid and solid materials of air and aluminum, 
respectively, will be present. Air will be replaced with the two phases of 
plasma and red blood cells, while aluminum will be kept unchanged. 
With Fluid highlighted, click “Create/Edit...” at the bottom of the 
Materials pane. The Create/Edit Materials window will open, where the 
settings highlighted in FIGURE 3.28 for plasma should be applied: 
  
FIGURE 3.28 - Create/Edit Materials Window for Plasma in Fluent 
In FIGURE 3.28, a density of 1,003 kg m-3 is used, and a viscosity of 
0.001 kg m-1 s-1 is used. Similar steps may be taken to define red blood 
cells as a material. For red blood cells, however, a density of 1,096 kg 
m-3 is used, and viscosity is inserted by changing its drop-down to “user-




is chosen as the viscosity in the User-Defined Functions window, as 
shown in FIGURE 3.29: 
  
FIGURE 3.29 - User-Defined Functions Window with car_yas_visc 
Viscosity Selection for Red Blood Cells in Fluent 
Click “OK” to activate the model, and click “Close” in the Create/Edit 
Materials window. It is noted that the car_yas_visc option will only be 
available after a user-defined function is interpreted, as in FIGURE 3.33. 
iv. Defining Phases.  Phases are defined by clicking List/Show All... above 
Phases under the Setting Up Physics tab in the ribbon. The Phases 
window will open, as shown in FIGURE 3.30: 
 




Ensure the primary (phase-1) and secondary (phase-2) phases are plasma 
and red blood cells, respectively, by clicking “Edit...” and choosing the 
proper material from the Phase Material drop-down. Red blood cells 
require additional settings for phasic definition. As such, enable 
Granular in the Secondary Phase window to reveal property input. This 
is shown in FIGURE 3.31, where the highlighted settings should be 
applied: 
 
FIGURE 3.31 - Secondary Phase Window in (a) General and with the 
(b) Granular Properties Magnified in Fluent 
Phasic interaction settings are changed by clicking “Interaction...” at the 
bottom of the Phases window seen in FIGURE 3.30. Interaction changes 
for virtual mass, lift, collisions, mass, surface tension, and interfacial 
area are available, but the drag coefficient is the only item in need of 
modification. Keeping all other interactions default, FIGURE 3.32 






FIGURE 3.32 - Phase Interaction Window in (a) General and with the 
(b) Drag Coefficient Settings Magnified in Fluent 
v. Interpreting a User-Defined Function and Setting User-Defined Scalars.  
To permit use of scalars, a user-defined function must first be read by 
Fluent. Click Functions → Interpreted... above User-Defined under the 
User-Defined tab in the ribbon. The Interpreted UDFs window will 
open. Click Browse... and locate the proper source code file. The 
resulting window is shown in FIGURE 3.33: 
 
FIGURE 3.33 - Interpreted UDFs Window in Fluent 
Click “Interpret” in the Interpreted UDFs window and then click 
“Close.” With this, scalar definition begins by clicking Scalars... above 






Defined Scalars window will open, where the settings highlighted in 
FIGURE 3.34 should be applied: 
 
FIGURE 3.34 - User-Defined Scalars Window for (a) Red Blood Cells 
and (b) Plasma in Fluent 
Click “OK” to confirm the addition of the two scalars. Viewing 
FIGURE 3.34, it is stated that phase-2 now represents red blood cells 
and Scalar0, while phase-1 now represents plasma and Scalar1. 
vi. Mean Ages of the Phases Using User-Defined Scalars - Scalar0.  It is 
initially noted that this subsection demonstrates the steps necessary for 
mean age calculation setup with respect to Scalar0, with analogous 
images of Scalar1 setup displayed in the succeeding subsection. 
Recognizing this, the material properties of red blood cells must be 
updated to reflect scalar impact. Reopen the Create/Edit Materials 
window for red blood cells, which will now include the UDS Diffusivity 






FIGURE 3.35 - Updated Create/Edit Materials Window for Scalar0 in 
Fluent 
UDS diffusivity is inserted by changing its drop-down to “defined-per-
uds” and clicking “Edit...” to the right of it. A coefficient is entered in 
the UDS Diffusion Coefficients window, as shown highlighted in 
FIGURE 3.36:  
 
FIGURE 3.36 - UDS Diffusion Coefficients Window for Scalar0 in 
Fluent 
Click “OK” to confirm the coefficient, and click “Change/Create” and 
then “Close” in the Create/Edit Materials window. With this, to apply 




the Tree hierarchy to display the Cell Zone Conditions pane. With the 
phase of red blood cells (phase-2) chosen in the Phase drop-down in the 
pane, click “Edit...” to open the Fluid window. Enable Source Terms and 
click “Edit...” to the right of User Scalar 0 under the Source Terms tab. 
This will open the User Scalar 0 sources window. The same magnitude 
of density for red blood cells used previously (1,096) should be entered 
as the constant value. This process, with proper settings highlighted, is 
shown in FIGURE 3.37: 
  
FIGURE 3.37 - Fluid and User Scalar 0 Sources Windows for Scalar0 in 
Fluent 
Click “OK” in both windows to confirm scalar zone application. Finally, 
to apply the scalar in the boundary conditions, click Boundary 
Conditions in the Tree hierarchy to display the Boundary Conditions 
pane. With phase-2 still chosen in the Phase drop-down in the pane, 
select the inlet boundary and click “Edit...” to open the Velocity Inlet 
window. Three tabs of options are available, and the settings to be 





FIGURE 3.38 - Velocity Inlet Window for Scalar0 Displaying (a) 
Momentum, (b) Multiphase, and (c) UDS Settings in Fluent 
Click “OK” to confirm the inlet boundary condition. With phase-2 still 







the outlet boundary and click “Edit...” to open the Pressure Outlet 
window. Two tabs of options are available, and the default settings to 
ensure are shown in FIGURE 3.39: 
 
FIGURE 3.39 - Pressure Outlet Window for Scalar0 Displaying (a) 
Multiphase and (b) UDS Settings in Fluent 
Click “OK” to confirm the outlet boundary condition. 
vii. Mean Ages of the Phases Using User-Defined Scalars - Scalar1.  While 
previous steps have defined the scalar for red blood cells, similar steps 
may be taken for scalar definition of plasma. FIGURES 3.40–44 display 






   
FIGURE 3.40 - Updated Create/Edit Materials Window for Scalar1 in 
Fluent 
  
FIGURE 3.41 - UDS Diffusion Coefficients Window for Scalar1 in 
Fluent 
 






FIGURE 3.43 - Velocity Inlet Window for Scalar1 Displaying (a) 
Momentum and (b) UDS Settings in Fluent 
 
FIGURE 3.44 - Pressure Outlet Window for Scalar1 Displaying UDS 






c. Solution.  The Solution group in the Tree hierarchy arranges solution setup and 
calculation task direction. 
i. Solution Methods.  Click Solution Methods in the Tree hierarchy to 
display the Solution Methods pane, and ensure the settings highlighted 
in FIGURE 3.45 are followed: 
 
FIGURE 3.45 - Solution Methods Pane in Fluent 
ii. Solution Controls.  Click Solution Controls in the Tree hierarchy to 
display the Solution Controls pane, and ensure the settings highlighted in 






 FIGURE 3.46 - Solution Controls Pane in (a) General and with the (b) 
Under-Relaxation Factors Magnified in Fluent 
It is noted that the value of User Scalar 0 shown in FIGURE 3.46(b) may 
need infrequent reduction if divergence errors emerge. As such, this 
value may be halved until divergence is mitigated and a solution is 
calculated. 
iii. Monitors.  Click Monitors in the Tree hierarchy to display the Monitors 
pane. Select Residuals - Print, Plot under Residuals, Statistic and Force 
Monitors in the pane, and click “Edit...” below it. The Residual Monitors 
window will open, where the settings highlighted in FIGURE 3.47 






FIGURE 3.47 - Residual Monitors Window in (a) General and with the 
(b) Equations Magnified in Fluent 
Click “OK” to confirm the residual monitor settings. 
iv. Solution Initialization.  Click Solution Initialization in the Tree 
hierarchy to display the Solution Initialization pane. With Hybrid 
Initialization chosen from the Initialization Methods options, click 
“Initialize.” Appropriate starting values are generated for necessary 
system components, but the initial zero values of the scalars must be 
changed manually to further assist in solution convergence. As such, 






and apply the nonzero values highlighted in FIGURE 3.48 for the 
scalars: 
 
FIGURE 3.48 - Solution Initialization Pane in (a) General and with the 
(b) Initial Values Magnified in Fluent 
Click “Initialize” again to prime the system for solution calculation. 
v. Run Calculation.  Click Run Calculation in the Tree hierarchy to display 
the Run Calculation pane, where the settings highlighted in FIGURE 






FIGURE 3.49 - Run Calculation Pane in Fluent 





IV. RESULTS AND DISCUSSION 
A. Scope of Investigated Patient Numbers, Source Renderings, and Created Slices 
Results are presented for 10 patient cases, five below and five above the 𝐹𝐹𝑅 
threshold of 0.80 reported by Min et al. (2015) as the value below which a cardiologist 
intervenes with stent placement to prevent ischemia. The 10 patient cases are listed in 
TABLE 4.1: 
TABLE 4.1 
VALUES OF 𝐹𝐹𝑅 AND COMPONENTS OF THE ARTERIAL TREE 
REPRESENTING THE PATIENT NUMBERS USED IN THIS INVESTIGATION 
The three-dimensional source renderings of low and high 𝐹𝐹𝑅 used for two-dimensional 







Number 𝑭𝑭𝑹 Arterial Tree Component 
004 0.76 
“low” 
mid left anterior descending 
005 0.75 mid right coronary 
017 0.72 left anterior descending 
019 0.76 posterior descending 
041 0.70 proximal left anterior descending 
045 0.83 
“high” 
mid left anterior descending 
046 0.98 distal right coronary 
058 0.98 proximal left circumflex 
061 0.97 mid right coronary 





FIGURE 4.1 - Depictions of the (a) Three-Dimensional Source Rendering and Two-









FIGURE 4.2 - Depictions of the (a) Three-Dimensional Source Rendering and Two-









FIGURE 4.3 - Depictions of the (a) Three-Dimensional Source Rendering and Two-









FIGURE 4.4 - Depictions of the (a) Three-Dimensional Source Rendering and Two-












FIGURE 4.5 - Depictions of the (a) Three-Dimensional Source Rendering and Two-









FIGURE 4.6 - Depictions of the (a) Three-Dimensional Source Rendering and Two-









FIGURE 4.7 - Depictions of the (a) Three-Dimensional Source Rendering and Two-









FIGURE 4.8 - Depictions of the (a) Three-Dimensional Source Rendering and Two-









FIGURE 4.9 - Depictions of the (a) Three-Dimensional Source Rendering and Two-









FIGURE 4.10 - Depictions of the (a) Three-Dimensional Source Rendering and Two-
Dimensional (b) Slice 1 and (c) Slice 2 for the Artery of Patient 075 
Fluent was used to simulate pulsing blood flow in each of the depictions shown in 
FIGURES 4.1–10 and to calculate the mean ages of the plasma and red blood cell phases 
using user-defined scalars. With Scalar1 representing plasma and Scalar0 representing 








plasma is believed to behave more as a continuous phase within blood, its flow may be 
less impacted by a stenosis than the fluid’s red blood cells. While red blood cells are not 
strictly granular, the granular method of modeling used for red blood cells is an attempt 
to create a simplified model of collision at a constriction within an artery. In using this 
setup, the red blood cell phase provides mean age data that the continuous, unaffecting 
plasma phase simply cannot. These data are shown in subsequent plots of Scalar0 mean 
age. For completeness, however, plots of Scalar1 mean age may be seen in APPENDIX 
II. 
B. Fluent Results of the Three-Dimensional Source Renderings 
Fluent was used to simulate pulsing blood flow in the three-dimensional source 
renderings while tracking a user-defined scalar (Scalar0), representing the mean age of 
red blood cells, over the duration of flow. The plots displayed in this subsection 
subsequently represent the mean age of red blood cells as a function of elapsed flow time. 
Plots of Scalar0 mean age typically resemble periodic behavior as a result of the pulsing 
boundary conditions. Increased peaks of mean age varying from standard periodicity, 
however, are indicators of stenotic character along the flow path as blood attempts to 
transport from inlet to outlet but is impeded. In other words, an increase in mean age is 
attributed to an obstructing stenosis. With this, the plots utilize area-weighted averaging 
of the scalar value instead of mass-weighted averaging. Mean age itself is a calculation of 
the average time of all material passing through a given location rather than the average 
time of all material wherever it may be in the system. As a result, area-weighted average 





The five cases of low 𝐹𝐹𝑅 are shown in FIGURES 4.11–15: 
   
  FIGURE 4.11 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source 
Rendering of Patient 004 
   
FIGURE 4.12 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source 
Rendering of Patient 005 
   
FIGURE 4.13 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source 




















































































   
FIGURE 4.14 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source 
Rendering of Patient 019 
   
FIGURE 4.15 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source 
Rendering of Patient 041 
As shown, each of the five low 𝐹𝐹𝑅 source renderings exhibit an increased peak of 
significantly large magnitude. The appearance of high peaks may be attributed to stenotic 
character present within a source rendering. With this, patients of lower 𝐹𝐹𝑅 value are 
observed to provide the highest elevation in peak. This is to say that Patient 041, with its 
𝐹𝐹𝑅 value of 0.70, displays the highest peak value, while Patients 004 and 019, with 
their 𝐹𝐹𝑅 value of 0.76, exhibit the lowest increase in mean age. These results align with 
the expectations associated with an 𝐹𝐹𝑅 value below 0.80 impacting an artery. 





















































   
FIGURE 4.16 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source 
Rendering of Patient 045 
   
FIGURE 4.17 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source 
Rendering of Patient 046 
   
FIGURE 4.18 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source 

















































































   
FIGURE 4.19 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source 
Rendering of Patient 061 
   
FIGURE 4.20 - Area-Weighted Average of Scalar0 for the Three-Dimensional Source 
Rendering of Patient 075 
As shown, three of the five high 𝐹𝐹𝑅 source renderings (i.e., those from Patients 045, 
046, and 058) exhibit the beginnings of periodicity and/or a slight peak of mean age 
value. As a whole, these source renderings align with the expectations governed by a high 
𝐹𝐹𝑅 value, which are expressed by their generally low mean age values. With this, 
however, there are increasingly elevated peaks present in the plots for Patients 061 and 
075. Nevertheless, these peaks do not reach the same magnitudes of elevation as shown 
in renderings of low 𝐹𝐹𝑅 value, and these increased peaks of mean age may be attributed 
























































C. Fluent Results of the Two-Dimensional Arterial Slices 
1. Plots of Scalar0 Mean Age and Nominal Mean Residence Time Comparison 
Fluent was used to simulate pulsing blood flow in the two-dimensional arterial 
slices while tracking a user-defined scalar (Scalar0), representing the mean age of red 
blood cells, over the duration of flow. Again, it is stated that increased peaks of mean age 
varying from standard periodicity are indicators of stenotic character along the flow path 
as blood attempts to transport from inlet to outlet but is impeded. Succeeding plots with 
increased peaks of mean age are shaded gold. With this, the plots utilize area-weighted 
averaging of the scalar value instead of mass-weighted averaging for the same reason 
explained in the preceding subsection. 
The five cases of low 𝐹𝐹𝑅 are shown in FIGURES 4.21–25: 
   
   



























































   
   
FIGURE 4.22 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of 
Patient 005 
   
   
FIGURE 4.23 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of 
Patient 017 
   
   


































































































































































   
   
FIGURE 4.25 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of 
Patient 041 
As shown, four out of the five low 𝐹𝐹𝑅 cases contain at least one slice (shaded in gold) 
with increased peaks of Scalar0 value. Patient 019 saw increased peaks in both arterial 
slices, while Patients 005, 017, and 041 contained increased peaks in only one of the two 
slices. The appearance (and non-appearance) of high peaks may be attributed to the 
arbitrarily chosen planes for slicing. As discussed in EXPERIMENTAL METHODS, 
splines were used to create orthogonal slices from a given three-dimensional STL file. 
Only two angles out of 360° were created, leading to the possibility of uncaptured 
stenotic character within the three-dimensional rendering. Since arteries (and renderings 
of them) are not perfectly cylindrical, the potential of observing increased peaks in plots 
of Scalar0 mean age is highly dependent on the angular direction chosen for any sliced 
plane. The limitation in capturing stenotic character is a possibility in using only two 
slices, and this idea serves to explain the unexpected slice singularities of constant peak 
value observed and left unshaded in Patients 004, 005, 017, and 041. 


























































   
   
FIGURE 4.26 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of 
Patient 045 
   
   
FIGURE 4.27 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of 
Patient 046 
   
   




































































































































































   
   
FIGURE 4.29 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of 
Patient 061 
   
   
FIGURE 4.30 - Area-Weighted Average of Scalar0 for (a) Slice 1 and (b) Slice 2 of 
Patient 075 
As shown, four out of the five high 𝐹𝐹𝑅 cases resemble periodic functions with a nearly 
constant peak value. In fact, aside from Slice 2 of Patient 075, all other slices across the 
five cases demonstrate expected behavior. Slice 2 of Patient 075 outlies the total data set 
and could be ascribed to natural features of the actual artery that may only be expressed 
at this one arbitrary angle. 
The peak data of the Scalar0 FIGURES may be tabulated to show the significant 
difference of mean age between low and high values of 𝐹𝐹𝑅. With this, peak data of the 









































































































times of blood flow if the geometry were not stenotic. The mean residence times are 
determined by dividing the volume of the three-dimensional source rendering by the 
volumetric flow rate governing the flow and dictated by the boundary conditions. The 
data containing mean age as a function of 𝐹𝐹𝑅 and its comparison to nominal mean 
residence time are shown in TABLE 4.2: 
TABLE 4.2 
A COMPARISON OF MEAN AGE VALUES BETWEEN LOW AND HIGH 𝐹𝐹𝑅 







Peak Scalar0 (Mean Age) Percent Difference (× 10–1) 
Slice 1 Slice 2 Slice 1 Slice 2 
004 0.76 
“low” 
1.4 × 10–1 8.8 × 10–1 8.3 × 10–1 53% 50% 
005 0.75 9.1 × 10–2 1.5 × 103 5.1 × 10–1 164778% 46% 
017 0.72 2.5 × 10–1 4.0 × 100 1.5 × 100 149% 48% 
019 0.76 1.5 × 10–1 1.6 × 103 2.3 × 101 111225% 1533% 
041 0.70 4.9 × 10–2 4.8 × 104 4.7 × 10–1 9672560% 86% 
045 0.83 
“high” 
2.7 × 10–1 5.3 × 10–1 5.3 × 10–1 9% 10% 
046 0.98 3.3 × 10–1 2.1 × 100 2.1 × 100 53% 53% 
058 0.98 3.5 × 10–1 7.1 × 10–1 7.4 × 10–1 11% 11% 
061 0.97 3.0 × 10–1 1.4 × 100 1.3 × 100 37% 36% 
075 0.81 2.2 × 10–2 6.6 × 10–1 2.2 × 104 291% 9809017% 
TABLE 4.2 may be used to emphasize the difference in mean age between low and high 
𝐹𝐹𝑅. While high 𝐹𝐹𝑅 cases are observed to range in orders of magnitude from tenths to 
ones, low 𝐹𝐹𝑅 cases generally exhibit a mean age increased by no less than one order of 
magnitude. Although not always the case (as in Patients 004 and 017), this observation 
serves to support the notion of mean age increasing as 𝐹𝐹𝑅 decreases. In addition to this, 




residence times. The values differ more greatly in cases of low 𝐹𝐹𝑅 than those for cases 
of high 𝐹𝐹𝑅, and this is enumerated in the columns of Percent Difference. With this, 
Slice 1 values for low 𝐹𝐹𝑅 cases are distinctly higher than respective ones for Slice 2, 
which is evidenced by the increased peaks shown previously in the gold-shaded plots in 
FIGURES 4.22–25. 
The directionality of a slice may have an effect in prompting increased mean age 
values, so it is noted here that Slice 1 and Slice 2 geometries were typically cut 
horizontally and vertically, respectively, to the trimetric view given by default in 
SpaceClaim. An example of this is shown in FIGURE 3.9 in EXPERIMENTAL 
METHODS. Resulting treatment in SolidWorks provided the slices shown in FIGURE 
4.6, where Slice 1 is now oriented in the XY-plane nearly vertically and Slice 2 is now 
oriented nearly horizontally. This procedure was used for all slice creation, provided that 
the curvature of the three-dimensional rendering permitted its fulfillment. As shown in 
FIGURES 4.1–10, most slices follow this orientation scheme, but there are exceptions 
(such as Patient 019 and Patient 046). In viewing these FIGURES and TABLE 4.2, 
however, the patients with increased mean age values do not appear to find a correlation 
with the orientation of the slice. Directly, while Slice 1 geometries are typically vertical 
and represent the cases where increased peaks in mean age are present, Patient 019 
displays increased mean age values while both slices are nearly horizontal. 
2. Plots of Velocity Contours 
The plots displayed in this subsection represent the computed velocity contours of 
the red blood cells phase. It is noted that velocity contours of the plasma phase are not 




range of velocity magnitude gradates from blue to red as velocity increases, and the slice-
specific spectrum of the velocity is shown in each of the depictions. The velocity 
contours for the five cases of low and five cases of high 𝐹𝐹𝑅 are shown, respectively, in 
FIGURES 4.31–35 and FIGURES 4.36–40: 
 
FIGURE 4.31 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 004 
 









FIGURE 4.33 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 017 
 









FIGURE 4.35 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 041 
 









FIGURE 4.37 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 046 
 









FIGURE 4.39 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 061 
 
FIGURE 4.40 - Velocity Contours for (a) Slice 1 and (b) Slice 2 of Patient 075 
The most observable difference between low and high 𝐹𝐹𝑅 cases stems from the location 
and progression of increased regions of velocity magnitude. For most cases of low 𝐹𝐹𝑅, 
regions of red color (high velocity) are confined to discrete spots. Blue/green regions 
(lower velocity) typically surround these spots, leading to proper representations of actual 








concentrations of increased velocity denote a stenosis and are validated by its plots of 
Scalar0 mean age (FIGURE 4.24) and TABLE 4.2 to cause an increased mean age. 
Contrastingly, instead of having discrete sites of increased velocity, most cases of high 
𝐹𝐹𝑅 exhibit extended lengths of red color throughout a large portion of the slice. This is 
attributed to the artery and its slice narrowing naturally along the length of the geometry 
without the presence of an actual stenosis. Patient 058 exemplifies this behavior, where a 
developed stretch of red color dominates most of both slices, producing no apparent 
increase in mean age. This is substantiated by the Scalar0 mean age plots shown in 
FIGURE 4.28 and the data of TABLE 4.2. From this, it is generalized that contours of 
slices displaying distinct locations of increased velocity as a result of a stenosis typically 
influences and dictates an increased mean age value, while those contours with extended, 
non-stenotic stretches of maximum velocity do not produce an increase in mean age. 
D. Three- and Two-Dimensional Comparison of Mean Age 
The mean age data from the three- and two-dimensional simulations may be 
compared in an attempt to determine a relationship between the two spatial approaches. 
This relationship is sought to determine if reliable results can be obtained that reduces 
computational runtime. Directly, CFD processing of three-dimensional flow is typified by 
considerably lengthier calculation runtimes when compared to those of two-dimensional 
geometries. While three-dimensional calculations often approach a total duration on the 
order of several hours, two-dimensional processing usually lasts on the order of about 60 
minutes, meaning only about 2% of alike runtime is needed. Ultimately, if two-
dimensional slicing can produce a similar mean age metric to its three-dimensional 




to aid in long-term three-dimensional correlative approaches to 𝐹𝐹𝑅. To develop the 
relationship of these spatial approaches, the comparison of the two is efficiently 
presented by plotting mean age as function of 𝐹𝐹𝑅. The data required for plotting, now 
sorting from lowest to highest 𝐹𝐹𝑅 value, are shown in TABLE 4.3: 
TABLE 4.3 
A COMPARISON OF MEAN AGE VALUES FOR THE THREE-DIMENSIONAL 
SOURCE RENDERINGS AND THE TWO-DIMENSIONAL ARTERIAL SLICES 
Patient Number 𝑭𝑭𝑹 
Peak Scalar0 (Mean Age) 
Source 
Rendering Slice 1 Slice 2 
041 0.70 
“low” 
2.9 × 1013 4.8 × 104 4.7 × 10–1 
017 0.72 4.6 × 108 4.0 × 100 1.5 × 100 
005 0.75 2.6 × 105 1.5 × 103 5.1 × 10–1 
004 0.76 1.1 × 105 8.8 × 10–1 8.3 × 10–1 
019 0.76 1.2 × 104 1.6 × 103 2.3 × 101 
075 0.81 
“high” 
8.6 × 103 6.6 × 10–1 2.2 × 104 
045 0.83 7.2 × 10–1 5.3 × 10–1 5.3 × 10–1 
061 0.97 9.0 × 102 1.4 × 100 1.3 × 100 
046 0.98 7.5 × 10–1 2.1 × 100 2.1 × 100 
058 0.98 8.6 × 10–1 7.1 × 10–1 7.4 × 10–1 
As shown in TABLE 4.3, the mean age values of the slices are contained within a smaller 
range in comparison to the source rendering values. Notably, however, TABLE 4.3 
serves to enumerate the difference in magnitudes between three- and two-dimensional 
processing of related cases as a result of an increasing 𝐹𝐹𝑅 value. Cases of high 𝐹𝐹𝑅 are 
typically within one order of magnitude between the source renderings and slices, while, 
in contrast, cases of low 𝐹𝐹𝑅 retain mean age values of the source renderings that are 
many orders of magnitude higher than those of the corresponding slices. The significant 
difference in orders of magnitude between three- and two-dimensional processing of low 




simplicity of the slices. It is believed that important stenotic proceedings onset and 
captured by the complexity of the full three-dimensional source renderings are not 
captured by the simplicity of the two-dimensional slices. This is to say that occurrences 
such as increased red blood cell collisions around a stenosis or an increase in 
recirculatory eddies distal to a stenosis may be less expressed in the two-dimensional 
slice systems. As a result, mean ages between the two spatial approaches are quantified 
by substantial disparity in order of magnitude. 
Setting the value of 𝐹𝐹𝑅 as the ordinate and the value of mean age as the abscissa 
of an ordered pair, the data of TABLE 4.3 may be plotted in order to aid in better 
visualization. It is noted that while data for Slice 2 are present in TABLE 4.3, they are 
shown for completeness and are not used for plotting in subsequent FIGURES. The 
previous subsection established that Slice 2 geometries generally provided no increased 
peak in mean age, so they are withheld from further discussion. Moreover, it is noted that 
source rendering data plotting is performed separately from Slice 1 data plotting. The 
increased magnitudes associated with the source renderings make normalization between 
its data and Slice 1 data largely ineffectual, so two plots of different scale are created 
separately and are shown hereafter 
The plot correlating mean age and 𝐹𝐹𝑅 for the three-dimensional source 





FIGURE 4.41 - Quadrant Plot Correlating the Mean Age of Red Blood Cells with 𝐹𝐹𝑅 
for the Three-Dimensional Source Rendering 
FIGURE 4.41 utilizes a vertical line at the previously identified 𝐹𝐹𝑅 threshold value of 
0.80. It is noted that data points to the left of this line dictate cardiological intervention, 
while values to the right of this line dictate no intervention. An analogous line of 
demarcation is needed for the threshold value of mean age. In order to split the plot into 
quadrants, the threshold value of mean age must be determined so as to maximize the 
number of data points in the upper left and bottom right portions of the plot. In doing so, 
the number of patients mean age is able to diagnose accurately will approach that of the 
ability of 𝐹𝐹𝑅. In order to properly determine this threshold value, extensive statistical 








































ANOVA and regression are used to test a large set of data to find patterns or trends. Since 
the 10 three-dimensional simulation results were previously gathered from a large study 
of 80 patients, the threshold value has been statistically determined, and its value is 2.2 × 
104. As such, a horizontal line is plotted at this value, which is shown in FIGURE 4.41, to 
further demarcate the data and split the plot into quadrants. 
 Quadrants I, II, III, and IV of FIGURE 4.41 represent specific regions of 
importance with regards to mean age and 𝐹𝐹𝑅 as diagnostics. As mentioned previously, 
maximizing the number of data points in Quadrants I and III is desired so as to bring 
mean age in close agreement with 𝐹𝐹𝑅. Data points in Quadrant I accurately predict 
withholding intervention necessity with low mean age and high 𝐹𝐹𝑅 values, while data 
points in Quadrant III accurately predict intervention necessity with high mean age and 
low 𝐹𝐹𝑅 values. In contrast, data points in Quadrants II and IV represent predictive 
errors in diagnosis and are sought to be minimized. Data points in Quadrant II are false 
positives that mistakenly suggest cardiological intervention is necessary, while data 
points in Quadrant IV are false negatives that mistakenly suggest intervention may be 
withheld. The tabulation of these medical statistics concerning FIGURE 4.41 is shown 
subsequently with Slice 1 data in TABLE 4.4. 
The plot correlating mean age and 𝐹𝐹𝑅 for the two-dimensional geometry of 





FIGURE 4.42 - Quadrant Plot Correlating the Mean Age of Red Blood Cells with 𝐹𝐹𝑅 
for the Two-Dimensional Geometry of Slice 1 
Similar to the plot for the three-dimensional source renderings, FIGURE 4.42 utilizes a 
vertical line at the previously identified 𝐹𝐹𝑅 threshold value of 0.80. Again, the 
analogous line of demarcation for the correct threshold value of mean age must be 
determined through statistical analysis. Rigorous tests in statistical analysis ultimately 
advance beyond the scope of this investigation due to the limited sample size of two-
dimensional cases, but an estimation of the threshold value is warranted for 
demonstrative purposes. Similar to the quadrant plot for the source renderings, it is 
recognized that the threshold value of mean age must seek to maximize the number of 































estimate achieving this goal, the threshold of mean age may be arbitrarily chosen as the 
value of 2.5 × 100. Directly, a horizontal line is plotted at this value, which is shown in 
FIGURE 4.42, to further demarcate the data and split the plot into quadrants. 
 Quadrants I, II, III, and IV of FIGURE 4.42 represent the same medically relevant 
regions described of FIGURE 4.41 previously. As such, the medical statistics of false 
positives and false negatives concerning FIGURES 4.41 and 4.42 are shown in TABLE 
4.4: 
TABLE 4.4 
TABULATION OF THE NUMBER OF OCCURRENCES OF PROPER DIAGNOSIS, 
FALSE POSITIVES, AND FALSE NEGATIVES OBSERVED IN THE QUADRANT 
PLOTS CORRELATING THE MEAN AGE OF RED BLOOD CELLS AND 𝐹𝐹𝑅 
System Occurrences of Proper Diagnosis False Positives False Negatives 
Three-Dimensional 
Source Rendering 9 0 1 
Slice 1 9 0 1 
As shown in TABLE 4.4, only one false negative for each spatial approach is present in 
the data when the statistical and arbitrary threshold values of 2.2 × 104 and 2.5 × 100 are 
used for the source renderings and Slice 1, respectively. While limited in sample size, 
false diagnosis is thusly 10% for each system. In literature, virtual approaches to 𝐹𝐹𝑅 
using larger sample sizes have shown false diagnostic values of 10–13% (Papafaklis et 
al., 2014; Tu et al., 2014; Tröbs et al., 2016). In order to maintain the presently 
competing approach that utilizes multiphase mean age theory, its false diagnostic 
percentages should not be greater than those of other virtual 𝐹𝐹𝑅 techniques. For the 




quantifying similarity between the spatial approaches, and the proper statistical 
determination of two-dimensional threshold will rely on this comparison in future 
research developments. It is noted that while both medical statistics represent 
incongruence with the predictions of 𝐹𝐹𝑅, the overdiagnosis of cardiological intervention 
is less problematic than that of underdiagnosing it. 
 With the data of the quadrant plots shown in full, it is again restated that the line 
of demarcation denoting the threshold value of mean age for the two-dimensional data 
was chosen arbitrarily. This value serves as a starting point to demonstrate the feasibility 
of two-dimensional slicing as a surrogate to equivalently processing a three-dimensional 
source rendering. As shown in the previous TABLES and FIGURES, two-dimensional 
slicing bolsters appreciable diagnostic similarity to three-dimensional processing when a 
subjective mean age threshold has been chosen. These results aid in administering the 
preliminary determination of two-dimensional slicing as a meritorious technique 
regarding cardiological context, but at least 80–100 data points are needed to confidently 
support this claim. Ultimately, with more testing and the employment of proper statistical 
analysis efforts, the threshold value of mean age related to the arterial slices may be 








A comparison of stenotic blood flow in two-dimensional arterial slices to flow in 
their three-dimensional source renderings was executed using CFD and multiphase mean 
age theory. Useful in present research attempting to unite angiography with a non-
invasive stenotic evaluator, a relationship between the three- and two-dimensional 
approaches was sought to obtain a comparable method of arterial simulation processing 
that significantly reduces computational runtime. Computer-aided design software 
packages were used to generate two orthogonal arterial slices from DICOM-derived, 
three-dimensional STL files of arteries rendered by coronary angiograms. Following 
mesh generation by the discretization of the domains of the created geometries, CFD 
software was employed to simulate pulsing blood flow in the geometries and to apply 
multiphase mean age theory to calculate the mean age of red blood cells using user-
defined scalars. Results were presented for five patient cases below and five patient cases 
above the commonly accepted 𝐹𝐹𝑅 threshold value of 0.80, below which cardiological 
intervention is prompted for stent placement as a mechanism to avert ischemia.  
In tracking the area-weighted average of mean age of red blood cells, plots of 
mean age throughout the duration of a complete pulse demonstrated peaks with higher 
orders of magnitude for cases with 𝐹𝐹𝑅 less than 0.80. The two-dimensional arterial 
slices typically exhibited this behavior in only the vertically-oriented geometries of Slice 
1. This was ascribed to the limitation of testing only two angles of a 360° arterial 
segment, which more than likely eventuated uncaptured stenotic character from the three-




if sliced at a proper angle, two-dimensional slices are able to distinguish between low and 
high 𝐹𝐹𝑅. 
The increases in mean age for the three-dimensional cases were many orders of 
magnitude higher than those of the corresponding two-dimensional cases. This was 
attributed to phenomena near a stenosis—such as red blood cell collisions or distal 
recirculatory eddies—being less expressed in the simplicity of the two-dimensional 
arterial slices when compared to the complex character of the full three-dimensional 
source renderings.  
Mean age data from the three- and two-dimensional simulations were compared 
using quadrant plots to establish the relationship between the two spatial approaches that 
administers the determination of two-dimensional slicing as a worthy technique regarding 
cardiological context and computational timeliness. Three-dimensional diagnostic ability 
was demonstrated by utilizing a statistically analyzed mean age threshold value of 2.2 × 
104, while an arbitrary threshold value (2.5 × 100) demarcating the diagnostic ability for 
two-dimensional processing was used since limited sample size impeded full statistical 
treatment to obtain it. While not fully statistically grounded, the arbitrary threshold was 
used in an analogous manner to that of the 𝐹𝐹𝑅 threshold value of 0.80 to depict the 
potentiality of slicing as a proxy to equivalently processing a source rendering. As a 
demonstration, this arbitrary value was utilized to indicate the capacity of proper medical 
pronouncement, where the medical statistics of false positives and false negatives were 
largely outweighed by it.  
While three-dimensional calculations often approached a total duration on the 




dimensional processing required on the order of about 60 minutes on a single processor, 
which is less than 2% of the required computing power of the three-dimensional cases. 
Preliminary results indicate two-dimensional processing retains compelling calculation 
merit and will be well positioned to efficiently detect and assess stenoses non-invasively, 























Foremost, an investment into researching other computer-aided design software 
should be made in an attempt to simplify and ease the process of generating arterial 
slices. As presented in EXPERIMENTAL METHODS, slice generation performed in 
SpaceClaim required a combination of tedious rotating, zooming, panning, and clicking 
of indiscriminate points along the length of the wall of an artery to create splines that 
represented three-dimensional arterial outlines. Researching and testing the capabilities of 
other commercially available software may lead to slice generation that is far more 
expeditious and aids in ensuring orthogonality of geometry is met. With this, as 
mentioned in RESULTS AND DISCUSSION, only two angles out of 360° were created, 
which lent credence to the possibility of stenotic character being uncaptured from the 
three-dimensional rendering. Ideally, in researching other computer-aided design 
software, the ability to revolve a single slice within the boundaries of a three-dimensional 
rendering may be discovered so as to foster swift slice generation and permit the creation 
of all angles automatically. In doing so, the results of blood flow simulation in all of the 
angles may be linked to provide conclusions that more closely mirror the baseline 
outcomes drawn from three-dimensional processing. 
Other recommendations stem from the amount of cases tested, statistical analysis, 
and the meshes used for simulation. Specifically, while 10 cases were analyzed in this 
investigation, more DICOM-derived, three-dimensional STL files of arteries rendered by 
coronary angiograms could be provided for slicing treatment in an attempt to increase the 
repeatability of results, establish better trends, and ultimately further the strength of 




value—with a concurrent employment of statistical analysis that establishes the proper 
threshold value of mean age—would serve to confidently govern the determination of 
two-dimensional slicing as a worthy cardiological technique when compared to alike 
processing in three-dimensions. Finally, in testing these extra cases, mesh sensitivity 
analysis could be performed as a way to determine whether increasing the element count 
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SAMPLE SOURCE CODE FOR A UDF FILE 
The following source code represents a UDF file that was used to generate pulsing at the 
boundaries: 
/********************************************************************* */ 
/*                                                             */ 
/* User-Defined Function for Transient Flow in a Channel       */ 
/*                                                             */ 
/* Fluent 6                                                    */ 
/*                                                             */ 
/* Author: Frank Kelecy                                        */ 
/*   Date: January 2001                                        */ 
/*                                                             */ 
/* This function prescribes an oscillating static pressure     */ 
/* at the channel exit.                                        */ 








  face_t f; 
 
  double t = (CURRENT_TIME*1.111-floor(CURRENT_TIME*1.111))/1.111; 
 
  begin_f_loop(f, th) 
  { 
   if(t <= 0.42)F_PROFILE(f, th, i) =0.1; else F_PROFILE(f,th,i) = 
0.26*sin(1.58*3.141592654*(t+0.92)); 
  } 













  double t = (CURRENT_TIME*1.111-floor(CURRENT_TIME*1.111))/1.111; 
 
  begin_f_loop(f, th) 
  { 
   if(t <= 0.42)F_PROFILE(f, th, i) 
=0.8*18665.13*sin(1.4*3.141592654*(0.8*t+0.1305)); else F_PROFILE(f,th,i) =(-
13400*t+22700)*0.8; 
  } 










































PLOTS OF SCALAR1 MEAN AGE 
Fluent was used to simulate pulsing blood flow while tracking a user-defined 
scalar (Scalar1), representing the mean age of plasma, over the duration of flow. Scalar1 
data for the three-dimensional source renderings were not reported, so the following plots 
are for the two-dimensional arterial slices. The five cases of low and five cases of high 
𝐹𝐹𝑅 are shown, respectively, in FIGURES A.1–5 and FIGURES A.6–10: 
   
   
FIGURE A.1 - Area-Weighted Average of Scalar1 for (a) Slice1 and (b) Slice2 of Patient 
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FIGURE A.3 - Area-Weighted Average of Scalar1 for (a) Slice1 and (b) Slice2 of Patient 
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FIGURE A.4 - Area-Weighted Average of Scalar1 for (a) Slice1 and (b) Slice2 of Patient 
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FIGURE A.6 - Area-Weighted Average of Scalar1 for (a) Slice1 and (b) Slice2 of Patient 
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FIGURE A.7 - Area-Weighted Average of Scalar1 for (a) Slice1 and (b) Slice2 of Patient 
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FIGURE A.9 - Area-Weighted Average of Scalar1 for (a) Slice1 and (b) Slice2 of Patient 
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